<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/stylesheet.xsl" type="text/xsl"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:podcast="https://podcastindex.org/namespace/1.0">
  <channel>
    <atom:link rel="self" type="application/atom+xml" href="https://feeds.transistor.fm/cvs-health-healthy-conversations" title="MP3 Audio"/>
    <atom:link rel="hub" href="https://pubsubhubbub.appspot.com/"/>
    <podcast:podping usesPodping="true"/>
    <title>Healthy Conversations</title>
    <generator>Transistor (https://transistor.fm)</generator>
    <itunes:new-feed-url>https://feeds.transistor.fm/cvs-health-healthy-conversations</itunes:new-feed-url>
    <description>Healthy Conversations brings together leaders and innovators in health care to talk about the biggest issues facing patients and providers today. Every month, we explore new topics to help uncover the clinical insights and emerging technologies transforming health care in real time.</description>
    <copyright>© 2020–2022 CVS Health</copyright>
    <podcast:guid>827c7e95-54e8-53af-acbb-c91ebfc822f4</podcast:guid>
    <podcast:locked owner="EllnerJ@cvshealth.com">no</podcast:locked>
    <language>en</language>
    <pubDate>Tue, 10 Dec 2024 06:00:12 -0500</pubDate>
    <lastBuildDate>Tue, 02 Dec 2025 16:32:11 -0500</lastBuildDate>
    <link>https://cvshealth.com/healthyconversations</link>
    <image>
      <url>https://img.transistor.fm/u1xHZd0c9UKRqPJPcYNpejUrZSs70ZHg--G7gvpR4LI/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzEyOTc1LzE2MTc5/ODkxMTAtYXJ0d29y/ay5qcGc.jpg</url>
      <title>Healthy Conversations</title>
      <link>https://cvshealth.com/healthyconversations</link>
    </image>
    <itunes:category text="Health &amp; Fitness"/>
    <itunes:category text="Science">
      <itunes:category text="Life Sciences"/>
    </itunes:category>
    <itunes:type>episodic</itunes:type>
    <itunes:author>CVS Health</itunes:author>
    <itunes:image href="https://img.transistor.fm/u1xHZd0c9UKRqPJPcYNpejUrZSs70ZHg--G7gvpR4LI/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzEyOTc1LzE2MTc5/ODkxMTAtYXJ0d29y/ay5qcGc.jpg"/>
    <itunes:summary>Healthy Conversations brings together leaders and innovators in health care to talk about the biggest issues facing patients and providers today. Every month, we explore new topics to help uncover the clinical insights and emerging technologies transforming health care in real time.</itunes:summary>
    <itunes:subtitle>Healthy Conversations brings together leaders and innovators in health care to talk about the biggest issues facing patients and providers today.</itunes:subtitle>
    <itunes:keywords>403121</itunes:keywords>
    <itunes:owner>
      <itunes:name>CVS Health</itunes:name>
    </itunes:owner>
    <itunes:complete>No</itunes:complete>
    <itunes:explicit>No</itunes:explicit>
    <item>
      <title>Going Digital in Suicide Prevention</title>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:title>Going Digital in Suicide Prevention</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">fed73160-5152-4718-b678-da71cb769e6a</guid>
      <link>https://share.transistor.fm/s/117f81c6</link>
      <description>
        <![CDATA[<p>We’re re-releasing a special two-part episode about innovations in suicide prevention in recognition of Suicide Prevention Awareness Month. In this second episode, Dr. Seth Feuerstein, the CEO of Oui Therapeutics, talks about his company’s digital therapeutics aimed at reducing suicide – which he calls “the only leading cause of death without any prescription products.” He speaks with our host, Dr. Daniel Kraft, about using software as a medical device and explains the road to FDA approval for his company’s products. Dr. Feuerstein describes their digital therapeutic as “a multidimensional interactive experience” that typically lasts 10 to 12 weeks under the direction of a clinician. “You might work with a chatbot function, you might interact with other patients, you might work on practicing exercises to refine the way you brain might react to certain situations,” he says. Studies about its effectiveness have been promising. </p><p> </p><p>Cara McNulty, President of Behavioral Health and Mental Well-being at CVS Health®, introduces this episode by looking at the many tools and programs available to help reduce suicide, including those listed below.</p><p><strong>Suicide prevention resources</strong></p><ul><li><a href="https://www.cvshealth.com/services/health-care-and-wellness/mental-health.html">CVS Health mental health resources</a></li><li><a href="https://ouitherapeutics.com/">Oui Therapeutics</a></li><li><a href="https://afsp.org/">American Foundation for Suicide Prevention</a></li><li><a href="https://www.mentalhealthfirstaid.org/">Mental Health First Aid</a></li><li><a href="https://www.thetrevorproject.org/">The Trevor Project</a></li><li><a href="https://jedfoundation.org/">The Jed Foundation</a></li></ul>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>We’re re-releasing a special two-part episode about innovations in suicide prevention in recognition of Suicide Prevention Awareness Month. In this second episode, Dr. Seth Feuerstein, the CEO of Oui Therapeutics, talks about his company’s digital therapeutics aimed at reducing suicide – which he calls “the only leading cause of death without any prescription products.” He speaks with our host, Dr. Daniel Kraft, about using software as a medical device and explains the road to FDA approval for his company’s products. Dr. Feuerstein describes their digital therapeutic as “a multidimensional interactive experience” that typically lasts 10 to 12 weeks under the direction of a clinician. “You might work with a chatbot function, you might interact with other patients, you might work on practicing exercises to refine the way you brain might react to certain situations,” he says. Studies about its effectiveness have been promising. </p><p> </p><p>Cara McNulty, President of Behavioral Health and Mental Well-being at CVS Health®, introduces this episode by looking at the many tools and programs available to help reduce suicide, including those listed below.</p><p><strong>Suicide prevention resources</strong></p><ul><li><a href="https://www.cvshealth.com/services/health-care-and-wellness/mental-health.html">CVS Health mental health resources</a></li><li><a href="https://ouitherapeutics.com/">Oui Therapeutics</a></li><li><a href="https://afsp.org/">American Foundation for Suicide Prevention</a></li><li><a href="https://www.mentalhealthfirstaid.org/">Mental Health First Aid</a></li><li><a href="https://www.thetrevorproject.org/">The Trevor Project</a></li><li><a href="https://jedfoundation.org/">The Jed Foundation</a></li></ul>]]>
      </content:encoded>
      <pubDate>Wed, 20 Sep 2023 03:01:00 -0400</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/117f81c6/abe727f1.mp3" length="50724516" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1267</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>We’re re-releasing a special two-part episode about innovations in suicide prevention in recognition of Suicide Prevention Awareness Month. In this second episode, Dr. Seth Feuerstein, the CEO of Oui Therapeutics, talks about his company’s digital therapeutics aimed at reducing suicide – which he calls “the only leading cause of death without any prescription products.” He speaks with our host, Dr. Daniel Kraft, about using software as a medical device and explains the road to FDA approval for his company’s products. Dr. Feuerstein describes their digital therapeutic as “a multidimensional interactive experience” that typically lasts 10 to 12 weeks under the direction of a clinician. “You might work with a chatbot function, you might interact with other patients, you might work on practicing exercises to refine the way you brain might react to certain situations,” he says. Studies about its effectiveness have been promising. </p><p> </p><p>Cara McNulty, President of Behavioral Health and Mental Well-being at CVS Health®, introduces this episode by looking at the many tools and programs available to help reduce suicide, including those listed below.</p><p><strong>Suicide prevention resources</strong></p><ul><li><a href="https://www.cvshealth.com/services/health-care-and-wellness/mental-health.html">CVS Health mental health resources</a></li><li><a href="https://ouitherapeutics.com/">Oui Therapeutics</a></li><li><a href="https://afsp.org/">American Foundation for Suicide Prevention</a></li><li><a href="https://www.mentalhealthfirstaid.org/">Mental Health First Aid</a></li><li><a href="https://www.thetrevorproject.org/">The Trevor Project</a></li><li><a href="https://jedfoundation.org/">The Jed Foundation</a></li></ul>]]>
      </itunes:summary>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/117f81c6/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Dispelling Misconceptions About Suicide</title>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:title>Dispelling Misconceptions About Suicide</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">2c0bc691-1e3b-4b88-a3ac-815f532cf1fe</guid>
      <link>https://share.transistor.fm/s/d483a89f</link>
      <description>
        <![CDATA[<p>In recognition of Suicide Prevention Awareness Month, today we’re re-releasing a special two-part episode with Dr. Seth Feuerstein, a psychiatrist and researcher who’s made the study and treatment of suicide his life’s work. Dr. Feuerstein is the CEO of Oui Therapeutics, which is building life-saving digital therapeutics to help in preventing suicide. He and our host, Dr. Daniel Kraft, have a wide-ranging discussion about misconceptions, data and innovations in suicide prevention. Dr. Feuerstein also challenges the way health care professionals think about suicide. “The suicidal state of the brain is a lot like the arrhythmia state of the heart,” he says. “It’s a relatively spontaneous period where there’s an elevated risk of sudden death.” Reframing our thinking about suicide in this way, Dr. Feuerstein explains, will make it easier for clinicians to talk about it.</p><p> </p><p>Cara McNulty, President of Behavioral Health and Mental Well-being at CVS Health®, introduces this episode by looking at the latest reporting from the Centers for Disease Control and Prevention (CDC), which says suicide rates in the U.S. are again on the rise. She discusses how CVS Health is using a systematic approach to reduce suicide attempts and raise awareness of suicide prevention. </p><p><strong>Suicide prevention resources</strong></p><ul><li><a href="https://www.cvshealth.com/services/health-care-and-wellness/mental-health.html">CVS Health mental health resources</a></li><li><a href="https://ouitherapeutics.com/">Oui Therapeutics</a></li><li><a href="https://afsp.org/">American Foundation for Suicide Prevention</a></li><li><a href="https://www.mentalhealthfirstaid.org/">Mental Health First Aid</a></li><li><a href="https://www.thetrevorproject.org/">The Trevor Project</a></li><li><a href="https://jedfoundation.org/">The Jed Foundation</a></li></ul>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In recognition of Suicide Prevention Awareness Month, today we’re re-releasing a special two-part episode with Dr. Seth Feuerstein, a psychiatrist and researcher who’s made the study and treatment of suicide his life’s work. Dr. Feuerstein is the CEO of Oui Therapeutics, which is building life-saving digital therapeutics to help in preventing suicide. He and our host, Dr. Daniel Kraft, have a wide-ranging discussion about misconceptions, data and innovations in suicide prevention. Dr. Feuerstein also challenges the way health care professionals think about suicide. “The suicidal state of the brain is a lot like the arrhythmia state of the heart,” he says. “It’s a relatively spontaneous period where there’s an elevated risk of sudden death.” Reframing our thinking about suicide in this way, Dr. Feuerstein explains, will make it easier for clinicians to talk about it.</p><p> </p><p>Cara McNulty, President of Behavioral Health and Mental Well-being at CVS Health®, introduces this episode by looking at the latest reporting from the Centers for Disease Control and Prevention (CDC), which says suicide rates in the U.S. are again on the rise. She discusses how CVS Health is using a systematic approach to reduce suicide attempts and raise awareness of suicide prevention. </p><p><strong>Suicide prevention resources</strong></p><ul><li><a href="https://www.cvshealth.com/services/health-care-and-wellness/mental-health.html">CVS Health mental health resources</a></li><li><a href="https://ouitherapeutics.com/">Oui Therapeutics</a></li><li><a href="https://afsp.org/">American Foundation for Suicide Prevention</a></li><li><a href="https://www.mentalhealthfirstaid.org/">Mental Health First Aid</a></li><li><a href="https://www.thetrevorproject.org/">The Trevor Project</a></li><li><a href="https://jedfoundation.org/">The Jed Foundation</a></li></ul>]]>
      </content:encoded>
      <pubDate>Wed, 13 Sep 2023 03:01:00 -0400</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/d483a89f/b781fdea.mp3" length="57546280" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1438</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In recognition of Suicide Prevention Awareness Month, today we’re re-releasing a special two-part episode with Dr. Seth Feuerstein, a psychiatrist and researcher who’s made the study and treatment of suicide his life’s work. Dr. Feuerstein is the CEO of Oui Therapeutics, which is building life-saving digital therapeutics to help in preventing suicide. He and our host, Dr. Daniel Kraft, have a wide-ranging discussion about misconceptions, data and innovations in suicide prevention. Dr. Feuerstein also challenges the way health care professionals think about suicide. “The suicidal state of the brain is a lot like the arrhythmia state of the heart,” he says. “It’s a relatively spontaneous period where there’s an elevated risk of sudden death.” Reframing our thinking about suicide in this way, Dr. Feuerstein explains, will make it easier for clinicians to talk about it.</p><p> </p><p>Cara McNulty, President of Behavioral Health and Mental Well-being at CVS Health®, introduces this episode by looking at the latest reporting from the Centers for Disease Control and Prevention (CDC), which says suicide rates in the U.S. are again on the rise. She discusses how CVS Health is using a systematic approach to reduce suicide attempts and raise awareness of suicide prevention. </p><p><strong>Suicide prevention resources</strong></p><ul><li><a href="https://www.cvshealth.com/services/health-care-and-wellness/mental-health.html">CVS Health mental health resources</a></li><li><a href="https://ouitherapeutics.com/">Oui Therapeutics</a></li><li><a href="https://afsp.org/">American Foundation for Suicide Prevention</a></li><li><a href="https://www.mentalhealthfirstaid.org/">Mental Health First Aid</a></li><li><a href="https://www.thetrevorproject.org/">The Trevor Project</a></li><li><a href="https://jedfoundation.org/">The Jed Foundation</a></li></ul>]]>
      </itunes:summary>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/d483a89f/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Can the Future of Healthy Aging Be at Home?</title>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:title>Can the Future of Healthy Aging Be at Home?</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">db2a6464-328e-498d-9b9c-c6e083d4b612</guid>
      <link>https://share.transistor.fm/s/819cac7e</link>
      <description>
        <![CDATA[<p>If you look around, you’ll probably notice that the U.S. population is getting older. In fact, one in five people will be retirement age by 2030. And the latest Health Trends Report, <em>The Future of Healthy Aging</em>, quotes the U.S. Census Bureau that three out of five people over the age of 65 manage two or more chronic conditions. “If we go back maybe 60 years or so, 40% of health care in America was delivered at home. Today it's only about 1% of care that is delivered at home,” Sree Chaguturu, MD, Executive Vice President and Chief Medical Officer, CVS Health, notes. “But when you ask people, especially seniors, ‘Where would you like to get care?’ Four out of five individuals say, ‘I would like to get care at home.’” The good thing is that while health care needs are growing for older adults, the options for value-based accessible local and at-home care services are expanding, as well.</p><p>In this <em>Healthy Conversations</em> episode, Dr. Chaguturu details different ways CVS Health is bringing care services directly into the neighborhoods of older adults. For instance, CVS’ acquisition of Signify Health is helping understand patients’ health risks with 2.5 million in-home evaluations, which it then shares with providers, primary care teams, and health plans. He concludes, “It's incredibly simple but fundamental. By just spending time in a patient's home, it really allows us to make sure that that patient is getting what they need, and it's customized for their particular health situation.”</p><p><br> Learn more</p><ul><li><a href="https://www.cvshealth.com/news/research-reports/health-trends.html">Health Trends Report</a>  </li><li> <a href="https://www.cvshealth.com/news/pharmacy/minuteclinic-recognized-for-national-age-friendly-health-systems.html">MinuteClinic Age-Friendly Health Systems Commitment</a></li><li> <a href="https://www.cvshealth.com/news/cvs-health-live/cvs-health-live-is-living-longer-living-better-embracing-healthy-aging.html">Embracing Healthy Aging</a></li></ul><p> <br> </p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>If you look around, you’ll probably notice that the U.S. population is getting older. In fact, one in five people will be retirement age by 2030. And the latest Health Trends Report, <em>The Future of Healthy Aging</em>, quotes the U.S. Census Bureau that three out of five people over the age of 65 manage two or more chronic conditions. “If we go back maybe 60 years or so, 40% of health care in America was delivered at home. Today it's only about 1% of care that is delivered at home,” Sree Chaguturu, MD, Executive Vice President and Chief Medical Officer, CVS Health, notes. “But when you ask people, especially seniors, ‘Where would you like to get care?’ Four out of five individuals say, ‘I would like to get care at home.’” The good thing is that while health care needs are growing for older adults, the options for value-based accessible local and at-home care services are expanding, as well.</p><p>In this <em>Healthy Conversations</em> episode, Dr. Chaguturu details different ways CVS Health is bringing care services directly into the neighborhoods of older adults. For instance, CVS’ acquisition of Signify Health is helping understand patients’ health risks with 2.5 million in-home evaluations, which it then shares with providers, primary care teams, and health plans. He concludes, “It's incredibly simple but fundamental. By just spending time in a patient's home, it really allows us to make sure that that patient is getting what they need, and it's customized for their particular health situation.”</p><p><br> Learn more</p><ul><li><a href="https://www.cvshealth.com/news/research-reports/health-trends.html">Health Trends Report</a>  </li><li> <a href="https://www.cvshealth.com/news/pharmacy/minuteclinic-recognized-for-national-age-friendly-health-systems.html">MinuteClinic Age-Friendly Health Systems Commitment</a></li><li> <a href="https://www.cvshealth.com/news/cvs-health-live/cvs-health-live-is-living-longer-living-better-embracing-healthy-aging.html">Embracing Healthy Aging</a></li></ul><p> <br> </p>]]>
      </content:encoded>
      <pubDate>Wed, 09 Aug 2023 03:00:00 -0400</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/819cac7e/5d3a2149.mp3" length="14914819" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>930</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>If you look around, you’ll probably notice that the U.S. population is getting older. In fact, one in five people will be retirement age by 2030. And the latest Health Trends Report, <em>The Future of Healthy Aging</em>, quotes the U.S. Census Bureau that three out of five people over the age of 65 manage two or more chronic conditions. “If we go back maybe 60 years or so, 40% of health care in America was delivered at home. Today it's only about 1% of care that is delivered at home,” Sree Chaguturu, MD, Executive Vice President and Chief Medical Officer, CVS Health, notes. “But when you ask people, especially seniors, ‘Where would you like to get care?’ Four out of five individuals say, ‘I would like to get care at home.’” The good thing is that while health care needs are growing for older adults, the options for value-based accessible local and at-home care services are expanding, as well.</p><p>In this <em>Healthy Conversations</em> episode, Dr. Chaguturu details different ways CVS Health is bringing care services directly into the neighborhoods of older adults. For instance, CVS’ acquisition of Signify Health is helping understand patients’ health risks with 2.5 million in-home evaluations, which it then shares with providers, primary care teams, and health plans. He concludes, “It's incredibly simple but fundamental. By just spending time in a patient's home, it really allows us to make sure that that patient is getting what they need, and it's customized for their particular health situation.”</p><p><br> Learn more</p><ul><li><a href="https://www.cvshealth.com/news/research-reports/health-trends.html">Health Trends Report</a>  </li><li> <a href="https://www.cvshealth.com/news/pharmacy/minuteclinic-recognized-for-national-age-friendly-health-systems.html">MinuteClinic Age-Friendly Health Systems Commitment</a></li><li> <a href="https://www.cvshealth.com/news/cvs-health-live/cvs-health-live-is-living-longer-living-better-embracing-healthy-aging.html">Embracing Healthy Aging</a></li></ul><p> <br> </p>]]>
      </itunes:summary>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/819cac7e/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>The Evolution and Challenges of Primary Care</title>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:title>The Evolution and Challenges of Primary Care</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">3c4719e4-b0c4-41f4-83a0-145bee230f68</guid>
      <link>https://share.transistor.fm/s/e7fa202f</link>
      <description>
        <![CDATA[<p>Primary care is the backbone of the health care system. So the question is, how do you keep the primary care system <em>itself</em> healthy? That’s the timely topic of this Healthy Conversations episode, where Sree Chaguturu, MD, Executive Vice President and Chief Medical Officer for CVS Health, addresses the challenges of delivering the right care at the right time, and in the right place. As he puts it, “Almost 80% of individuals in America say that they're unsatisfied with their current health care experience. The average wait time to see a primary care physician is almost one month. But when you do have primary care, great things happen.”</p><p>While primary care has been largely under-invested in over the last few decades, Dr. Chaguturu notes that the development of an omnichannel health care approach – in person, in clinic, virtually, or at home – is helping amplify accessibility. He also describes how an emphasis on value-based care can benefit both HCPs and consumers. In the end, as he says, “There is not going to be one right answer. We need all of these different models to succeed, to get primary care to a better state than what it is today.”</p><p><br><strong>Learn more</strong></p><ul><li><a href="https://www.cvshealth.com/services/health-care-and-wellness/primary-care.html">Primary care services</a></li><li><a href="https://www.cvshealth.com/news/virtual-care/cvs-health-to-launch-new-virtual-primary-care-solution-on-single.html">Virtual primary care</a></li></ul><p> </p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Primary care is the backbone of the health care system. So the question is, how do you keep the primary care system <em>itself</em> healthy? That’s the timely topic of this Healthy Conversations episode, where Sree Chaguturu, MD, Executive Vice President and Chief Medical Officer for CVS Health, addresses the challenges of delivering the right care at the right time, and in the right place. As he puts it, “Almost 80% of individuals in America say that they're unsatisfied with their current health care experience. The average wait time to see a primary care physician is almost one month. But when you do have primary care, great things happen.”</p><p>While primary care has been largely under-invested in over the last few decades, Dr. Chaguturu notes that the development of an omnichannel health care approach – in person, in clinic, virtually, or at home – is helping amplify accessibility. He also describes how an emphasis on value-based care can benefit both HCPs and consumers. In the end, as he says, “There is not going to be one right answer. We need all of these different models to succeed, to get primary care to a better state than what it is today.”</p><p><br><strong>Learn more</strong></p><ul><li><a href="https://www.cvshealth.com/services/health-care-and-wellness/primary-care.html">Primary care services</a></li><li><a href="https://www.cvshealth.com/news/virtual-care/cvs-health-to-launch-new-virtual-primary-care-solution-on-single.html">Virtual primary care</a></li></ul><p> </p>]]>
      </content:encoded>
      <pubDate>Wed, 26 Jul 2023 03:01:00 -0400</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/e7fa202f/e3d894d8.mp3" length="41002605" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1024</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Primary care is the backbone of the health care system. So the question is, how do you keep the primary care system <em>itself</em> healthy? That’s the timely topic of this Healthy Conversations episode, where Sree Chaguturu, MD, Executive Vice President and Chief Medical Officer for CVS Health, addresses the challenges of delivering the right care at the right time, and in the right place. As he puts it, “Almost 80% of individuals in America say that they're unsatisfied with their current health care experience. The average wait time to see a primary care physician is almost one month. But when you do have primary care, great things happen.”</p><p>While primary care has been largely under-invested in over the last few decades, Dr. Chaguturu notes that the development of an omnichannel health care approach – in person, in clinic, virtually, or at home – is helping amplify accessibility. He also describes how an emphasis on value-based care can benefit both HCPs and consumers. In the end, as he says, “There is not going to be one right answer. We need all of these different models to succeed, to get primary care to a better state than what it is today.”</p><p><br><strong>Learn more</strong></p><ul><li><a href="https://www.cvshealth.com/services/health-care-and-wellness/primary-care.html">Primary care services</a></li><li><a href="https://www.cvshealth.com/news/virtual-care/cvs-health-to-launch-new-virtual-primary-care-solution-on-single.html">Virtual primary care</a></li></ul><p> </p>]]>
      </itunes:summary>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/e7fa202f/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Taking Clinical Innovation in Health Care to the Next Level</title>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:title>Taking Clinical Innovation in Health Care to the Next Level</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">a6df5137-2df8-4917-8170-db7ddaaa72d5</guid>
      <link>https://share.transistor.fm/s/e7a74015</link>
      <description>
        <![CDATA[<p>While the health care industry can be challenging, with complex regulations and long-established bureaucracies, an innovative company called Redesign Health is working to transform it from within. Redesign Health is one of a number of organizations that received fresh funding last fall to boost health care startups from <a href="https://www.cvshealth.com/health-care-redefined/ventures.html">CVS Health Ventures</a>, a unit of CVS Health which focuses on data-driven medicine and digital health investments. And in just the last five years, Redesign’s New York-based team of about 300 has helped launch more than 50 tech-enabled health care businesses – providing not only talent and capital, but the scaffolding and support to launch them.</p><p>Neil Patel, head of New Ventures at <a href="https://www.redesignhealth.com/">Redesign Health</a>, explains how they’ve already improved patient care and touched the lives of more than 10 million people across health verticals that include treating cancer, tele-audiology, senior care, COVID-19 testing, metabolic health, as well as mental health. As he notes, “There's no shortage of problems to solve in health care, the question is the when and the how, as opposed to if you should do it.” Patel is joined by Andrea Messina, executive director and partner at CVS Health Ventures, who characterizes the investment in Redesign Health as an indirect opportunity to sustain and build new companies. "They take a lot of the most, as we see it, difficult elements of starting a new company out of the equation for prospective founders," Messina says.</p><p><br>Learn more</p><ul><li><a href="https://www.cvshealth.com/health-care-redefined/ventures.html">CVS Health Ventures</a></li><li><a href="https://www.redesignhealth.com/">Redesign Health</a></li></ul>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>While the health care industry can be challenging, with complex regulations and long-established bureaucracies, an innovative company called Redesign Health is working to transform it from within. Redesign Health is one of a number of organizations that received fresh funding last fall to boost health care startups from <a href="https://www.cvshealth.com/health-care-redefined/ventures.html">CVS Health Ventures</a>, a unit of CVS Health which focuses on data-driven medicine and digital health investments. And in just the last five years, Redesign’s New York-based team of about 300 has helped launch more than 50 tech-enabled health care businesses – providing not only talent and capital, but the scaffolding and support to launch them.</p><p>Neil Patel, head of New Ventures at <a href="https://www.redesignhealth.com/">Redesign Health</a>, explains how they’ve already improved patient care and touched the lives of more than 10 million people across health verticals that include treating cancer, tele-audiology, senior care, COVID-19 testing, metabolic health, as well as mental health. As he notes, “There's no shortage of problems to solve in health care, the question is the when and the how, as opposed to if you should do it.” Patel is joined by Andrea Messina, executive director and partner at CVS Health Ventures, who characterizes the investment in Redesign Health as an indirect opportunity to sustain and build new companies. "They take a lot of the most, as we see it, difficult elements of starting a new company out of the equation for prospective founders," Messina says.</p><p><br>Learn more</p><ul><li><a href="https://www.cvshealth.com/health-care-redefined/ventures.html">CVS Health Ventures</a></li><li><a href="https://www.redesignhealth.com/">Redesign Health</a></li></ul>]]>
      </content:encoded>
      <pubDate>Wed, 12 Jul 2023 03:01:00 -0400</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/e7a74015/b81b858c.mp3" length="52593660" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1314</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>While the health care industry can be challenging, with complex regulations and long-established bureaucracies, an innovative company called Redesign Health is working to transform it from within. Redesign Health is one of a number of organizations that received fresh funding last fall to boost health care startups from <a href="https://www.cvshealth.com/health-care-redefined/ventures.html">CVS Health Ventures</a>, a unit of CVS Health which focuses on data-driven medicine and digital health investments. And in just the last five years, Redesign’s New York-based team of about 300 has helped launch more than 50 tech-enabled health care businesses – providing not only talent and capital, but the scaffolding and support to launch them.</p><p>Neil Patel, head of New Ventures at <a href="https://www.redesignhealth.com/">Redesign Health</a>, explains how they’ve already improved patient care and touched the lives of more than 10 million people across health verticals that include treating cancer, tele-audiology, senior care, COVID-19 testing, metabolic health, as well as mental health. As he notes, “There's no shortage of problems to solve in health care, the question is the when and the how, as opposed to if you should do it.” Patel is joined by Andrea Messina, executive director and partner at CVS Health Ventures, who characterizes the investment in Redesign Health as an indirect opportunity to sustain and build new companies. "They take a lot of the most, as we see it, difficult elements of starting a new company out of the equation for prospective founders," Messina says.</p><p><br>Learn more</p><ul><li><a href="https://www.cvshealth.com/health-care-redefined/ventures.html">CVS Health Ventures</a></li><li><a href="https://www.redesignhealth.com/">Redesign Health</a></li></ul>]]>
      </itunes:summary>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/e7a74015/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Why Good Health Means Your Mental Health, Too</title>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:title>Why Good Health Means Your Mental Health, Too</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">9acccb92-3bb5-44fa-8e60-0c9e0436dfc1</guid>
      <link>https://share.transistor.fm/s/2f424628</link>
      <description>
        <![CDATA[<p>How are we doing right now in terms of mental health in the United States?  According to Dr. Taft Parsons III, the Chief Psychiatric Officer at CVS Health, the situation is alarming: “Before COVID, we already knew that there was more need for mental health services than there were clinicians. And so we have seen an increased demand across all age groups, across all demographics taking place over the last couple years.” In a recent CVS Health Trends report, 39% of providers admitted to having a high level of concern about the mental health of their patients over 65. At the other end of the age spectrum, three in five teen girls felt persistently sad or hopeless in the latest research from the CDC.</p><p>On this episode, Dr. Parsons talks about the importance of identifying people who are at risk for social isolation and providing greater access to care. As he says, one silver lining from the pandemic is that “There was kind of this acceptance of people talking about their emotional needs. If you ignore it, if you cover it up, you suffer all sorts of other health effects.”</p><p>Learn more  </p><ul><li><a href="https://www.cvshealth.com/news/research-reports/health-trends/the-future-of-healthy-aging.html">Health Trends Report: The Future of Healthy Aging</a></li><li><a href="https://www.cvshealth.com/services/health-care-and-wellness/mental-health.html">Mental health services from CVS Health</a></li></ul>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>How are we doing right now in terms of mental health in the United States?  According to Dr. Taft Parsons III, the Chief Psychiatric Officer at CVS Health, the situation is alarming: “Before COVID, we already knew that there was more need for mental health services than there were clinicians. And so we have seen an increased demand across all age groups, across all demographics taking place over the last couple years.” In a recent CVS Health Trends report, 39% of providers admitted to having a high level of concern about the mental health of their patients over 65. At the other end of the age spectrum, three in five teen girls felt persistently sad or hopeless in the latest research from the CDC.</p><p>On this episode, Dr. Parsons talks about the importance of identifying people who are at risk for social isolation and providing greater access to care. As he says, one silver lining from the pandemic is that “There was kind of this acceptance of people talking about their emotional needs. If you ignore it, if you cover it up, you suffer all sorts of other health effects.”</p><p>Learn more  </p><ul><li><a href="https://www.cvshealth.com/news/research-reports/health-trends/the-future-of-healthy-aging.html">Health Trends Report: The Future of Healthy Aging</a></li><li><a href="https://www.cvshealth.com/services/health-care-and-wellness/mental-health.html">Mental health services from CVS Health</a></li></ul>]]>
      </content:encoded>
      <pubDate>Wed, 21 Jun 2023 03:01:00 -0400</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/2f424628/fbc5258a.mp3" length="47776366" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1194</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>How are we doing right now in terms of mental health in the United States?  According to Dr. Taft Parsons III, the Chief Psychiatric Officer at CVS Health, the situation is alarming: “Before COVID, we already knew that there was more need for mental health services than there were clinicians. And so we have seen an increased demand across all age groups, across all demographics taking place over the last couple years.” In a recent CVS Health Trends report, 39% of providers admitted to having a high level of concern about the mental health of their patients over 65. At the other end of the age spectrum, three in five teen girls felt persistently sad or hopeless in the latest research from the CDC.</p><p>On this episode, Dr. Parsons talks about the importance of identifying people who are at risk for social isolation and providing greater access to care. As he says, one silver lining from the pandemic is that “There was kind of this acceptance of people talking about their emotional needs. If you ignore it, if you cover it up, you suffer all sorts of other health effects.”</p><p>Learn more  </p><ul><li><a href="https://www.cvshealth.com/news/research-reports/health-trends/the-future-of-healthy-aging.html">Health Trends Report: The Future of Healthy Aging</a></li><li><a href="https://www.cvshealth.com/services/health-care-and-wellness/mental-health.html">Mental health services from CVS Health</a></li></ul>]]>
      </itunes:summary>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/2f424628/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>The Impact of Genomics is Closer Than You Think</title>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:title>The Impact of Genomics is Closer Than You Think</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">294cb7d8-f315-40c2-a3ff-3249924ab52d</guid>
      <link>https://share.transistor.fm/s/b3cb3351</link>
      <description>
        <![CDATA[<p>Genomics may seem like a field of study with minimal impact on our daily lives. But not for much longer — and certainly not to Dr. Deepak Srivastava, a cardiologist and president of the Gladstone Institutes. Rapid technological advances in this field are starting to surface across health care with significant and promising benefits. “The new world,” says Dr. Srivastava, “is going to be one where, as we identify the known genetic causes, we no longer have to accept that that mutation exists. We finally in medicine have the opportunity to think about curing disease.”</p><p>The nonprofit Gladstone Institutes focuses on four key disease areas – the heart, brain (including Alzheimer’s and Parkinson’s), viral (like HIV and Covid), as well as immunologic disorders. On this episode of Healthy Conversations, Dr. Srivastava tells about advances like reprogramming support cells in the pancreas into new insulin-producing cells for diabetes: “So we can take skin or blood cells from any adult and turn those into cells that behave just like a human embryonic stem cell, which has the property that it can become once again any of our over 200 different cell types in the body.” The future may indeed be here, sooner than you think.    </p><p>Learn more<br> https://gladstone.org/</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Genomics may seem like a field of study with minimal impact on our daily lives. But not for much longer — and certainly not to Dr. Deepak Srivastava, a cardiologist and president of the Gladstone Institutes. Rapid technological advances in this field are starting to surface across health care with significant and promising benefits. “The new world,” says Dr. Srivastava, “is going to be one where, as we identify the known genetic causes, we no longer have to accept that that mutation exists. We finally in medicine have the opportunity to think about curing disease.”</p><p>The nonprofit Gladstone Institutes focuses on four key disease areas – the heart, brain (including Alzheimer’s and Parkinson’s), viral (like HIV and Covid), as well as immunologic disorders. On this episode of Healthy Conversations, Dr. Srivastava tells about advances like reprogramming support cells in the pancreas into new insulin-producing cells for diabetes: “So we can take skin or blood cells from any adult and turn those into cells that behave just like a human embryonic stem cell, which has the property that it can become once again any of our over 200 different cell types in the body.” The future may indeed be here, sooner than you think.    </p><p>Learn more<br> https://gladstone.org/</p>]]>
      </content:encoded>
      <pubDate>Wed, 07 Jun 2023 03:01:00 -0400</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/b3cb3351/700660f8.mp3" length="51918768" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1297</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Genomics may seem like a field of study with minimal impact on our daily lives. But not for much longer — and certainly not to Dr. Deepak Srivastava, a cardiologist and president of the Gladstone Institutes. Rapid technological advances in this field are starting to surface across health care with significant and promising benefits. “The new world,” says Dr. Srivastava, “is going to be one where, as we identify the known genetic causes, we no longer have to accept that that mutation exists. We finally in medicine have the opportunity to think about curing disease.”</p><p>The nonprofit Gladstone Institutes focuses on four key disease areas – the heart, brain (including Alzheimer’s and Parkinson’s), viral (like HIV and Covid), as well as immunologic disorders. On this episode of Healthy Conversations, Dr. Srivastava tells about advances like reprogramming support cells in the pancreas into new insulin-producing cells for diabetes: “So we can take skin or blood cells from any adult and turn those into cells that behave just like a human embryonic stem cell, which has the property that it can become once again any of our over 200 different cell types in the body.” The future may indeed be here, sooner than you think.    </p><p>Learn more<br> https://gladstone.org/</p>]]>
      </itunes:summary>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/b3cb3351/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>How Genomics Can Benefit Us All</title>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:title>How Genomics Can Benefit Us All</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">b128954e-3383-4753-b5d4-b569b59dd6a6</guid>
      <link>https://share.transistor.fm/s/343efec6</link>
      <description>
        <![CDATA[<p>It’s been more than 20 years since the human genome was first sequenced.  And now, a new version that’s been updated with 47 men and women of diverse origins, including African Americans, East Asians, West Africans, and South Americans, among others, promises to benefit all people, regardless of their race, ethnicity or ancestry. This new version, called the “pangenome,” was announced earlier this month by the National Human Genome Research Institute, a government agency that funded the research.</p><p>On this episode of <em>Healthy Conversations</em>, Trish Brown, the Genomics and Precision Medicine Program Director for CVS Health, details for Dr. Kraft how we can translate genomics into access to care, and what’s the human impact, going forward.  “So what we're capable of, now, in terms of isolating, finding DNA and what we can do with it at different stages is just incredible,” Trish notes.  “We have next generation sequencing testing platforms where if you wanted to, you could sequence the entire human genome and then you use bioinformatic filters to just pull out of that what you think is relevant. And so those sorts of technological advances have really dropped the cost and really allowed for a broader set of testing.”</p><p> </p><p>Learn more</p><ul><li><a href="https://www.aetna.com/health-guide/dna-health-testing-facts.html">6 Things to know about genetic testing</a> </li><li><a href="https://apnews.com/direct/?prx_t=wlkHA-lBTAYfwQA&amp;ntv_acpl=1113185&amp;ntv_acsc=0&amp;ntv_ot=0&amp;ntv_ui=9420badc-1ef9-4df7-a035-bc53eaf1bf15&amp;ntv_ht=9z5iZAA%5d">The value of genetic testing</a> </li></ul>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>It’s been more than 20 years since the human genome was first sequenced.  And now, a new version that’s been updated with 47 men and women of diverse origins, including African Americans, East Asians, West Africans, and South Americans, among others, promises to benefit all people, regardless of their race, ethnicity or ancestry. This new version, called the “pangenome,” was announced earlier this month by the National Human Genome Research Institute, a government agency that funded the research.</p><p>On this episode of <em>Healthy Conversations</em>, Trish Brown, the Genomics and Precision Medicine Program Director for CVS Health, details for Dr. Kraft how we can translate genomics into access to care, and what’s the human impact, going forward.  “So what we're capable of, now, in terms of isolating, finding DNA and what we can do with it at different stages is just incredible,” Trish notes.  “We have next generation sequencing testing platforms where if you wanted to, you could sequence the entire human genome and then you use bioinformatic filters to just pull out of that what you think is relevant. And so those sorts of technological advances have really dropped the cost and really allowed for a broader set of testing.”</p><p> </p><p>Learn more</p><ul><li><a href="https://www.aetna.com/health-guide/dna-health-testing-facts.html">6 Things to know about genetic testing</a> </li><li><a href="https://apnews.com/direct/?prx_t=wlkHA-lBTAYfwQA&amp;ntv_acpl=1113185&amp;ntv_acsc=0&amp;ntv_ot=0&amp;ntv_ui=9420badc-1ef9-4df7-a035-bc53eaf1bf15&amp;ntv_ht=9z5iZAA%5d">The value of genetic testing</a> </li></ul>]]>
      </content:encoded>
      <pubDate>Wed, 24 May 2023 03:01:00 -0400</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/343efec6/a6ecf315.mp3" length="62852192" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1571</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>It’s been more than 20 years since the human genome was first sequenced.  And now, a new version that’s been updated with 47 men and women of diverse origins, including African Americans, East Asians, West Africans, and South Americans, among others, promises to benefit all people, regardless of their race, ethnicity or ancestry. This new version, called the “pangenome,” was announced earlier this month by the National Human Genome Research Institute, a government agency that funded the research.</p><p>On this episode of <em>Healthy Conversations</em>, Trish Brown, the Genomics and Precision Medicine Program Director for CVS Health, details for Dr. Kraft how we can translate genomics into access to care, and what’s the human impact, going forward.  “So what we're capable of, now, in terms of isolating, finding DNA and what we can do with it at different stages is just incredible,” Trish notes.  “We have next generation sequencing testing platforms where if you wanted to, you could sequence the entire human genome and then you use bioinformatic filters to just pull out of that what you think is relevant. And so those sorts of technological advances have really dropped the cost and really allowed for a broader set of testing.”</p><p> </p><p>Learn more</p><ul><li><a href="https://www.aetna.com/health-guide/dna-health-testing-facts.html">6 Things to know about genetic testing</a> </li><li><a href="https://apnews.com/direct/?prx_t=wlkHA-lBTAYfwQA&amp;ntv_acpl=1113185&amp;ntv_acsc=0&amp;ntv_ot=0&amp;ntv_ui=9420badc-1ef9-4df7-a035-bc53eaf1bf15&amp;ntv_ht=9z5iZAA%5d">The value of genetic testing</a> </li></ul>]]>
      </itunes:summary>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/343efec6/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Fighting Mental Health Stigma </title>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:title>Fighting Mental Health Stigma </itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">a66e0eae-6249-4de4-9520-5103b21b3616</guid>
      <link>https://share.transistor.fm/s/a80d1129</link>
      <description>
        <![CDATA[<p>Are Americans underestimating their mental health struggles? A new study from CVS Health and Harris Poll found that nearly three in four Americans describe their mental health as “excellent” or “good,” and only one in 10 say their mental health has gotten worse in the last year. Yet nearly 60% of physicians report declining mental health among their patients. Why aren’t more people willing to talk about their feelings of anxiety, sadness, or the “blues”? In honor of Mental Health Awareness Month, we present a special episode from LinkedIn’s Anxious Achiever podcast featuring, Cara McNulty, President, Behavioral Health and Mental Well-being at CVS Health. “Mental well-being is part of our physical well-being, which is a part of our total well-being,” says Cara. “Instead of trying to pretend that our head is not attached to our bodies, let's reframe how we talk about mental well-being.” </p><p><br></p><p>In the interview with host Morra Aarons-Mele, Cara traces her career path as a population scientist along with her personal and professional experience with mental health. Cara and Morra open up about their mental health challenges as mothers and talk about the persistent myths around mental illness in our culture and health care system.   “Mental illness just means a chronic condition that you're dealing with like schizophrenia, like bipolar,: explains Cara. “That doesn't mean you're broken. … We don't tell people who have colon cancer that they're broken.”</p><p><br></p><p>Learn more </p><ul><li><a href="https://www.cvshealth.com/content/dam/enterprise/cvs-enterprise/pdfs/cvs-health-suicide-prevention-were-committed-to-reducing-suicide-attempts-young-adults.pdf">Mental health awareness guide for young adults (PDF)</a></li><li><a href="https://www.cvshealth.com/content/dam/enterprise/cvs-enterprise/pdfs/cvs-health-suicide-prevention-were-committed-to-reducing-suicide-attempts-parents-and-caregivers.pdf">Mental health awareness guide for parents and caregivers (PDF)</a></li><li><a href="https://podcasts.apple.com/us/podcast/the-anxious-achiever/id1480904163">LinkedIn Presents: The Anxious Achiever</a> </li></ul>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Are Americans underestimating their mental health struggles? A new study from CVS Health and Harris Poll found that nearly three in four Americans describe their mental health as “excellent” or “good,” and only one in 10 say their mental health has gotten worse in the last year. Yet nearly 60% of physicians report declining mental health among their patients. Why aren’t more people willing to talk about their feelings of anxiety, sadness, or the “blues”? In honor of Mental Health Awareness Month, we present a special episode from LinkedIn’s Anxious Achiever podcast featuring, Cara McNulty, President, Behavioral Health and Mental Well-being at CVS Health. “Mental well-being is part of our physical well-being, which is a part of our total well-being,” says Cara. “Instead of trying to pretend that our head is not attached to our bodies, let's reframe how we talk about mental well-being.” </p><p><br></p><p>In the interview with host Morra Aarons-Mele, Cara traces her career path as a population scientist along with her personal and professional experience with mental health. Cara and Morra open up about their mental health challenges as mothers and talk about the persistent myths around mental illness in our culture and health care system.   “Mental illness just means a chronic condition that you're dealing with like schizophrenia, like bipolar,: explains Cara. “That doesn't mean you're broken. … We don't tell people who have colon cancer that they're broken.”</p><p><br></p><p>Learn more </p><ul><li><a href="https://www.cvshealth.com/content/dam/enterprise/cvs-enterprise/pdfs/cvs-health-suicide-prevention-were-committed-to-reducing-suicide-attempts-young-adults.pdf">Mental health awareness guide for young adults (PDF)</a></li><li><a href="https://www.cvshealth.com/content/dam/enterprise/cvs-enterprise/pdfs/cvs-health-suicide-prevention-were-committed-to-reducing-suicide-attempts-parents-and-caregivers.pdf">Mental health awareness guide for parents and caregivers (PDF)</a></li><li><a href="https://podcasts.apple.com/us/podcast/the-anxious-achiever/id1480904163">LinkedIn Presents: The Anxious Achiever</a> </li></ul>]]>
      </content:encoded>
      <pubDate>Wed, 10 May 2023 03:00:00 -0400</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/a80d1129/51321791.mp3" length="39299373" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>2454</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Are Americans underestimating their mental health struggles? A new study from CVS Health and Harris Poll found that nearly three in four Americans describe their mental health as “excellent” or “good,” and only one in 10 say their mental health has gotten worse in the last year. Yet nearly 60% of physicians report declining mental health among their patients. Why aren’t more people willing to talk about their feelings of anxiety, sadness, or the “blues”? In honor of Mental Health Awareness Month, we present a special episode from LinkedIn’s Anxious Achiever podcast featuring, Cara McNulty, President, Behavioral Health and Mental Well-being at CVS Health. “Mental well-being is part of our physical well-being, which is a part of our total well-being,” says Cara. “Instead of trying to pretend that our head is not attached to our bodies, let's reframe how we talk about mental well-being.” </p><p><br></p><p>In the interview with host Morra Aarons-Mele, Cara traces her career path as a population scientist along with her personal and professional experience with mental health. Cara and Morra open up about their mental health challenges as mothers and talk about the persistent myths around mental illness in our culture and health care system.   “Mental illness just means a chronic condition that you're dealing with like schizophrenia, like bipolar,: explains Cara. “That doesn't mean you're broken. … We don't tell people who have colon cancer that they're broken.”</p><p><br></p><p>Learn more </p><ul><li><a href="https://www.cvshealth.com/content/dam/enterprise/cvs-enterprise/pdfs/cvs-health-suicide-prevention-were-committed-to-reducing-suicide-attempts-young-adults.pdf">Mental health awareness guide for young adults (PDF)</a></li><li><a href="https://www.cvshealth.com/content/dam/enterprise/cvs-enterprise/pdfs/cvs-health-suicide-prevention-were-committed-to-reducing-suicide-attempts-parents-and-caregivers.pdf">Mental health awareness guide for parents and caregivers (PDF)</a></li><li><a href="https://podcasts.apple.com/us/podcast/the-anxious-achiever/id1480904163">LinkedIn Presents: The Anxious Achiever</a> </li></ul>]]>
      </itunes:summary>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>Autism Advocate Temple Grandin on Neurodivergent Thinking</title>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:title>Autism Advocate Temple Grandin on Neurodivergent Thinking</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">d2673ea0-2182-422a-81fd-386a2fd0a0b6</guid>
      <link>https://share.transistor.fm/s/a57812de</link>
      <description>
        <![CDATA[<p>A recent CDC study reported that one in 36 children in the United States is diagnosed with autism. Today’s guest, Temple Grandin, is one of the country’s most renowned voices on autism with an incredible ability to open up and share her perspective on the world with us. A professor of animal science at Colorado State University, Grandin has been a pioneer in improving the welfare of farm animals for decades. She is the author or co-author of more than 60 scientific papers on animal behavior and more than a dozen books that include the best-sellers “Thinking in Pictures” (which became an HBO movie starring Claire Danes) and “Animals in Translation.” </p><p>Her latest book, “Visual Thinking,” explores neurodivergent thinking and the different ways our brains are wired. As she explains, “I didn't know until I was [in my] late thirties that other people thought in words. Everything [for me] comes up like snapshots and little mini-videos, and it was a shock for me to learn that other people were not visual thinkers.” In honor of Autism Acceptance Month, Temple spoke with Dr. Kraft about how the perception of autism has changed and how diversity of thinking makes us all stronger: “I think we need to have collaborations between the different kinds of thinkers, recognize that the different kinds of thinking exist and look at where there are complementary skills.”</p><p>Learn more<br><a href="https://www.templegrandin.com/">Temple Grandin</a></p><p><a href="https://www.cvshealth.com/">CVSHealth.com</a></p><p><br></p><p> </p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>A recent CDC study reported that one in 36 children in the United States is diagnosed with autism. Today’s guest, Temple Grandin, is one of the country’s most renowned voices on autism with an incredible ability to open up and share her perspective on the world with us. A professor of animal science at Colorado State University, Grandin has been a pioneer in improving the welfare of farm animals for decades. She is the author or co-author of more than 60 scientific papers on animal behavior and more than a dozen books that include the best-sellers “Thinking in Pictures” (which became an HBO movie starring Claire Danes) and “Animals in Translation.” </p><p>Her latest book, “Visual Thinking,” explores neurodivergent thinking and the different ways our brains are wired. As she explains, “I didn't know until I was [in my] late thirties that other people thought in words. Everything [for me] comes up like snapshots and little mini-videos, and it was a shock for me to learn that other people were not visual thinkers.” In honor of Autism Acceptance Month, Temple spoke with Dr. Kraft about how the perception of autism has changed and how diversity of thinking makes us all stronger: “I think we need to have collaborations between the different kinds of thinkers, recognize that the different kinds of thinking exist and look at where there are complementary skills.”</p><p>Learn more<br><a href="https://www.templegrandin.com/">Temple Grandin</a></p><p><a href="https://www.cvshealth.com/">CVSHealth.com</a></p><p><br></p><p> </p>]]>
      </content:encoded>
      <pubDate>Wed, 26 Apr 2023 03:00:00 -0400</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/a57812de/10b7c6e2.mp3" length="14863320" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>927</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>A recent CDC study reported that one in 36 children in the United States is diagnosed with autism. Today’s guest, Temple Grandin, is one of the country’s most renowned voices on autism with an incredible ability to open up and share her perspective on the world with us. A professor of animal science at Colorado State University, Grandin has been a pioneer in improving the welfare of farm animals for decades. She is the author or co-author of more than 60 scientific papers on animal behavior and more than a dozen books that include the best-sellers “Thinking in Pictures” (which became an HBO movie starring Claire Danes) and “Animals in Translation.” </p><p>Her latest book, “Visual Thinking,” explores neurodivergent thinking and the different ways our brains are wired. As she explains, “I didn't know until I was [in my] late thirties that other people thought in words. Everything [for me] comes up like snapshots and little mini-videos, and it was a shock for me to learn that other people were not visual thinkers.” In honor of Autism Acceptance Month, Temple spoke with Dr. Kraft about how the perception of autism has changed and how diversity of thinking makes us all stronger: “I think we need to have collaborations between the different kinds of thinkers, recognize that the different kinds of thinking exist and look at where there are complementary skills.”</p><p>Learn more<br><a href="https://www.templegrandin.com/">Temple Grandin</a></p><p><a href="https://www.cvshealth.com/">CVSHealth.com</a></p><p><br></p><p> </p>]]>
      </itunes:summary>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>Diversity in Clinical Trials Leads to Richer Data  </title>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:title>Diversity in Clinical Trials Leads to Richer Data  </itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">6185db00-dad6-4ca5-b67e-fe0b998552e8</guid>
      <link>https://share.transistor.fm/s/1f42d28f</link>
      <description>
        <![CDATA[<p>In part two of our conversation on clinical trials, we hear from two people directly involved in the effort to expand access to clinical trials in underserved communities. “There are challenges across the board, both in getting patients into studies and also getting them to stay in studies — what’s called retention,” says our first guest, Josh Rose, Vice President and Head of Clinical Trial Delivery, Site Solutions and Strategy for Clinical Trial Services at CVS Health. He explains how his team chose the 100 MinuteClinic sites to equip for clinical trials from among the more than 1,100 locations nationwide: “We specifically picked out those locations [near] the type of patient population that we were hoping to enroll – urban areas, areas with high patient density, areas with high diversity. That helps ensure that we are getting much more representation of the broader population.”</p><p> </p><p>Clinical Trial Services works with numerous trial sponsors, from large pharmaceutical companies like Moderna to smaller biotech firms like ProKidney, which is working on cell-based therapies to slow down and prevent kidney failure in order to help patients avoid the need for dialysis or a kidney transplant. Dr. Joseph Stavas, Senior Vice President of Global Clinical Development at ProKidney, explains how their innovative cell therapy approach harvests a patient’s own cells, which are then processed, formulated and reinjected. Chronic kidney disease, says Dr. Stavas, is predicted to be one of the largest global problems in the next 20 to 30 years. Their Phase 3 trial is targeting the two most common causes of chronic kidney disease — hypertension and type 2 diabetes.</p><p> </p><p>Learn more</p><p><a href="https://www.cvsclinicaltrials.com/">CVS Health Clinical Trial Services</a><br> <a href="https://prokidney.com/">ProKidney</a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In part two of our conversation on clinical trials, we hear from two people directly involved in the effort to expand access to clinical trials in underserved communities. “There are challenges across the board, both in getting patients into studies and also getting them to stay in studies — what’s called retention,” says our first guest, Josh Rose, Vice President and Head of Clinical Trial Delivery, Site Solutions and Strategy for Clinical Trial Services at CVS Health. He explains how his team chose the 100 MinuteClinic sites to equip for clinical trials from among the more than 1,100 locations nationwide: “We specifically picked out those locations [near] the type of patient population that we were hoping to enroll – urban areas, areas with high patient density, areas with high diversity. That helps ensure that we are getting much more representation of the broader population.”</p><p> </p><p>Clinical Trial Services works with numerous trial sponsors, from large pharmaceutical companies like Moderna to smaller biotech firms like ProKidney, which is working on cell-based therapies to slow down and prevent kidney failure in order to help patients avoid the need for dialysis or a kidney transplant. Dr. Joseph Stavas, Senior Vice President of Global Clinical Development at ProKidney, explains how their innovative cell therapy approach harvests a patient’s own cells, which are then processed, formulated and reinjected. Chronic kidney disease, says Dr. Stavas, is predicted to be one of the largest global problems in the next 20 to 30 years. Their Phase 3 trial is targeting the two most common causes of chronic kidney disease — hypertension and type 2 diabetes.</p><p> </p><p>Learn more</p><p><a href="https://www.cvsclinicaltrials.com/">CVS Health Clinical Trial Services</a><br> <a href="https://prokidney.com/">ProKidney</a></p>]]>
      </content:encoded>
      <pubDate>Wed, 12 Apr 2023 03:00:00 -0400</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/1f42d28f/aed7f633.mp3" length="22877452" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1427</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In part two of our conversation on clinical trials, we hear from two people directly involved in the effort to expand access to clinical trials in underserved communities. “There are challenges across the board, both in getting patients into studies and also getting them to stay in studies — what’s called retention,” says our first guest, Josh Rose, Vice President and Head of Clinical Trial Delivery, Site Solutions and Strategy for Clinical Trial Services at CVS Health. He explains how his team chose the 100 MinuteClinic sites to equip for clinical trials from among the more than 1,100 locations nationwide: “We specifically picked out those locations [near] the type of patient population that we were hoping to enroll – urban areas, areas with high patient density, areas with high diversity. That helps ensure that we are getting much more representation of the broader population.”</p><p> </p><p>Clinical Trial Services works with numerous trial sponsors, from large pharmaceutical companies like Moderna to smaller biotech firms like ProKidney, which is working on cell-based therapies to slow down and prevent kidney failure in order to help patients avoid the need for dialysis or a kidney transplant. Dr. Joseph Stavas, Senior Vice President of Global Clinical Development at ProKidney, explains how their innovative cell therapy approach harvests a patient’s own cells, which are then processed, formulated and reinjected. Chronic kidney disease, says Dr. Stavas, is predicted to be one of the largest global problems in the next 20 to 30 years. Their Phase 3 trial is targeting the two most common causes of chronic kidney disease — hypertension and type 2 diabetes.</p><p> </p><p>Learn more</p><p><a href="https://www.cvsclinicaltrials.com/">CVS Health Clinical Trial Services</a><br> <a href="https://prokidney.com/">ProKidney</a></p>]]>
      </itunes:summary>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/1f42d28f/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Getting More — and Different — Patients into Clinical Trials </title>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:title>Getting More — and Different — Patients into Clinical Trials </itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">de5ba1b0-5d8d-46bc-a7e8-077095b9bdf3</guid>
      <link>https://share.transistor.fm/s/290ba553</link>
      <description>
        <![CDATA[<p>Today, in the first of a two-part episode on increasing diversity in clinical trials, we hear from Dr. Owen Garrick, Chief Medical Officer of Clinical Trial Services at CVS Health. The unit, launched in 2021, is creating a network of clinical research sites by equipping certain HealthHUB and MinuteClinic locations with the staff and resources needed to conduct complex clinical trial protocols. The goal is to expand access to clinical trials in underserved communities and encourage a more diverse population to enroll, leading to more effective outcomes. “Historically, there has just been less diverse participation in studies,” notes Dr. Garrick. “The risk is, if we don’t solve this issue around lack of diversity in clinical trials, as we get to precision medicine, we’re only going to exacerbate health inequity.”</p><p><br></p><p>This new model combines precision patient recruitment from a diverse population with trial delivery and real-world evidence generation. Dr. Garrick believes it will be successful because it breaks down several of the barriers to trial participation – outreach to know a trial exists, convenience and, importantly, trust. “You already know CVS Health because you go for part of your health care, whether that’s retail prescriptions or specialty prescriptions or over-the-counter meds or MinuteClinic. So, you have this relationship that already exists,” he says. “As we introduce clinical trials and additional health care services, there’s this built-in trust.”</p><p> </p><p>Learn more</p><p><a href="https://www.cvsclinicaltrials.com/">CVS Health Clinical Trial Services</a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Today, in the first of a two-part episode on increasing diversity in clinical trials, we hear from Dr. Owen Garrick, Chief Medical Officer of Clinical Trial Services at CVS Health. The unit, launched in 2021, is creating a network of clinical research sites by equipping certain HealthHUB and MinuteClinic locations with the staff and resources needed to conduct complex clinical trial protocols. The goal is to expand access to clinical trials in underserved communities and encourage a more diverse population to enroll, leading to more effective outcomes. “Historically, there has just been less diverse participation in studies,” notes Dr. Garrick. “The risk is, if we don’t solve this issue around lack of diversity in clinical trials, as we get to precision medicine, we’re only going to exacerbate health inequity.”</p><p><br></p><p>This new model combines precision patient recruitment from a diverse population with trial delivery and real-world evidence generation. Dr. Garrick believes it will be successful because it breaks down several of the barriers to trial participation – outreach to know a trial exists, convenience and, importantly, trust. “You already know CVS Health because you go for part of your health care, whether that’s retail prescriptions or specialty prescriptions or over-the-counter meds or MinuteClinic. So, you have this relationship that already exists,” he says. “As we introduce clinical trials and additional health care services, there’s this built-in trust.”</p><p> </p><p>Learn more</p><p><a href="https://www.cvsclinicaltrials.com/">CVS Health Clinical Trial Services</a></p>]]>
      </content:encoded>
      <pubDate>Wed, 29 Mar 2023 03:00:00 -0400</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/290ba553/40592cae.mp3" length="19020153" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1186</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Today, in the first of a two-part episode on increasing diversity in clinical trials, we hear from Dr. Owen Garrick, Chief Medical Officer of Clinical Trial Services at CVS Health. The unit, launched in 2021, is creating a network of clinical research sites by equipping certain HealthHUB and MinuteClinic locations with the staff and resources needed to conduct complex clinical trial protocols. The goal is to expand access to clinical trials in underserved communities and encourage a more diverse population to enroll, leading to more effective outcomes. “Historically, there has just been less diverse participation in studies,” notes Dr. Garrick. “The risk is, if we don’t solve this issue around lack of diversity in clinical trials, as we get to precision medicine, we’re only going to exacerbate health inequity.”</p><p><br></p><p>This new model combines precision patient recruitment from a diverse population with trial delivery and real-world evidence generation. Dr. Garrick believes it will be successful because it breaks down several of the barriers to trial participation – outreach to know a trial exists, convenience and, importantly, trust. “You already know CVS Health because you go for part of your health care, whether that’s retail prescriptions or specialty prescriptions or over-the-counter meds or MinuteClinic. So, you have this relationship that already exists,” he says. “As we introduce clinical trials and additional health care services, there’s this built-in trust.”</p><p> </p><p>Learn more</p><p><a href="https://www.cvsclinicaltrials.com/">CVS Health Clinical Trial Services</a></p>]]>
      </itunes:summary>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/290ba553/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Spurring Innovation in Service of Health Equity</title>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:title>Spurring Innovation in Service of Health Equity</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">5d80e8b9-6606-4784-85e1-612f197809cc</guid>
      <link>https://share.transistor.fm/s/8a6808fd</link>
      <description>
        <![CDATA[<p>In part two of our conversation about the Clinical Entrepreneur Programme from England’s National Health Service, our host, Dr. Daniel Kraft, continues his discussion with Dr. Tony Young, the program’s founder. They talk about a number of innovations brought about through the program, including two aimed at addressing health disparities. CardMedic uses a collection of “digital flashcards” to help improve communication between health care staff and patients across barriers ranging from physical impairment to language to PPE. And Written Medicine’s software uses human-generated translations to provide medication labels in 11 languages – and counting. To encourage innovations like these, the entrepreneur program is building a “health inequalities tool” to help potential entrepreneurs answer questions like, “Am I bringing in unconscious bias? Is this going to make health equity worse?”</p><p> </p><p>In addition, Dr. Young offers a number of tips for potential physician entrepreneurs, including the importance of persistence and surrounding yourself with like-minded people. He encourages entrepreneurs to be open to change. “Don’t fall in love with your solution,” he says. “Too many people go, ‘I’ve got just the perfect answer for this,’ but it’s not. Actually, fall in love with the problem and really work that through. And then bring people onboard that share that problem and really want it solved.”</p><p><br></p><p> </p><p><strong>Learn more</strong></p><p><a href="https://nhscep.com/about-us/">NHS Clinical Entrepreneur Programme</a></p><p><a href="https://writtenmedicine.com/about.php">Written Medicine</a></p><p><a href="https://www.cardmedic.com/en-us/">CardMedic</a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In part two of our conversation about the Clinical Entrepreneur Programme from England’s National Health Service, our host, Dr. Daniel Kraft, continues his discussion with Dr. Tony Young, the program’s founder. They talk about a number of innovations brought about through the program, including two aimed at addressing health disparities. CardMedic uses a collection of “digital flashcards” to help improve communication between health care staff and patients across barriers ranging from physical impairment to language to PPE. And Written Medicine’s software uses human-generated translations to provide medication labels in 11 languages – and counting. To encourage innovations like these, the entrepreneur program is building a “health inequalities tool” to help potential entrepreneurs answer questions like, “Am I bringing in unconscious bias? Is this going to make health equity worse?”</p><p> </p><p>In addition, Dr. Young offers a number of tips for potential physician entrepreneurs, including the importance of persistence and surrounding yourself with like-minded people. He encourages entrepreneurs to be open to change. “Don’t fall in love with your solution,” he says. “Too many people go, ‘I’ve got just the perfect answer for this,’ but it’s not. Actually, fall in love with the problem and really work that through. And then bring people onboard that share that problem and really want it solved.”</p><p><br></p><p> </p><p><strong>Learn more</strong></p><p><a href="https://nhscep.com/about-us/">NHS Clinical Entrepreneur Programme</a></p><p><a href="https://writtenmedicine.com/about.php">Written Medicine</a></p><p><a href="https://www.cardmedic.com/en-us/">CardMedic</a></p>]]>
      </content:encoded>
      <pubDate>Wed, 15 Mar 2023 03:00:00 -0400</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/8a6808fd/2052fd92.mp3" length="14422918" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>899</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In part two of our conversation about the Clinical Entrepreneur Programme from England’s National Health Service, our host, Dr. Daniel Kraft, continues his discussion with Dr. Tony Young, the program’s founder. They talk about a number of innovations brought about through the program, including two aimed at addressing health disparities. CardMedic uses a collection of “digital flashcards” to help improve communication between health care staff and patients across barriers ranging from physical impairment to language to PPE. And Written Medicine’s software uses human-generated translations to provide medication labels in 11 languages – and counting. To encourage innovations like these, the entrepreneur program is building a “health inequalities tool” to help potential entrepreneurs answer questions like, “Am I bringing in unconscious bias? Is this going to make health equity worse?”</p><p> </p><p>In addition, Dr. Young offers a number of tips for potential physician entrepreneurs, including the importance of persistence and surrounding yourself with like-minded people. He encourages entrepreneurs to be open to change. “Don’t fall in love with your solution,” he says. “Too many people go, ‘I’ve got just the perfect answer for this,’ but it’s not. Actually, fall in love with the problem and really work that through. And then bring people onboard that share that problem and really want it solved.”</p><p><br></p><p> </p><p><strong>Learn more</strong></p><p><a href="https://nhscep.com/about-us/">NHS Clinical Entrepreneur Programme</a></p><p><a href="https://writtenmedicine.com/about.php">Written Medicine</a></p><p><a href="https://www.cardmedic.com/en-us/">CardMedic</a></p>]]>
      </itunes:summary>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/8a6808fd/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>How the NHS Evolved to Support Physician Entrepreneurs </title>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:title>How the NHS Evolved to Support Physician Entrepreneurs </itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">91b012b9-72c0-4408-9b9d-d65db413137a</guid>
      <link>https://share.transistor.fm/s/f9bd435e</link>
      <description>
        <![CDATA[<p>Clinicians are problem solvers by nature but taking an idea for a new innovation from concept to commercial market is not a skill widely taught in medical school. In 2015, England’s National Health Service (NHS) launched a Clinical Entrepreneur Programme to help provide just that type of knowledge and expertise. Our host, Dr. Daniel Kraft, speaks with Dr. Tony Young, the founder of that program who is an avid entrepreneur himself. Young is helping the NHS retain some of their brightest talent by fostering an entrepreneurial spirit in his colleagues and making connections where he can. The program has trained more than 1,000 clinical entrepreneurs, who’ve founded more than 350 startups, raised more than $500 million pounds, and impacted more than 100 million patients and professionals in the UK and beyond. You’ll hear all about Dr. Young’s career journey and the incredible innovations his colleagues are bringing to operating rooms as well as remote parts of the world. However, “the greatest medical innovation of all time,” says Young, “are the people who work in our Health Services, because they help put everything into action.” </p><p><strong>Learn more</strong></p><p><a href="https://nhscep.com/about-us/">NHS Clinical Entrepreneur Programme</a></p><p> </p><p> </p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Clinicians are problem solvers by nature but taking an idea for a new innovation from concept to commercial market is not a skill widely taught in medical school. In 2015, England’s National Health Service (NHS) launched a Clinical Entrepreneur Programme to help provide just that type of knowledge and expertise. Our host, Dr. Daniel Kraft, speaks with Dr. Tony Young, the founder of that program who is an avid entrepreneur himself. Young is helping the NHS retain some of their brightest talent by fostering an entrepreneurial spirit in his colleagues and making connections where he can. The program has trained more than 1,000 clinical entrepreneurs, who’ve founded more than 350 startups, raised more than $500 million pounds, and impacted more than 100 million patients and professionals in the UK and beyond. You’ll hear all about Dr. Young’s career journey and the incredible innovations his colleagues are bringing to operating rooms as well as remote parts of the world. However, “the greatest medical innovation of all time,” says Young, “are the people who work in our Health Services, because they help put everything into action.” </p><p><strong>Learn more</strong></p><p><a href="https://nhscep.com/about-us/">NHS Clinical Entrepreneur Programme</a></p><p> </p><p> </p>]]>
      </content:encoded>
      <pubDate>Tue, 28 Feb 2023 03:00:00 -0500</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/f9bd435e/83ec5985.mp3" length="16061992" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1001</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Clinicians are problem solvers by nature but taking an idea for a new innovation from concept to commercial market is not a skill widely taught in medical school. In 2015, England’s National Health Service (NHS) launched a Clinical Entrepreneur Programme to help provide just that type of knowledge and expertise. Our host, Dr. Daniel Kraft, speaks with Dr. Tony Young, the founder of that program who is an avid entrepreneur himself. Young is helping the NHS retain some of their brightest talent by fostering an entrepreneurial spirit in his colleagues and making connections where he can. The program has trained more than 1,000 clinical entrepreneurs, who’ve founded more than 350 startups, raised more than $500 million pounds, and impacted more than 100 million patients and professionals in the UK and beyond. You’ll hear all about Dr. Young’s career journey and the incredible innovations his colleagues are bringing to operating rooms as well as remote parts of the world. However, “the greatest medical innovation of all time,” says Young, “are the people who work in our Health Services, because they help put everything into action.” </p><p><strong>Learn more</strong></p><p><a href="https://nhscep.com/about-us/">NHS Clinical Entrepreneur Programme</a></p><p> </p><p> </p>]]>
      </itunes:summary>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/f9bd435e/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Speeding Up Care Delivery for GI Patients </title>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:title>Speeding Up Care Delivery for GI Patients </itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">574e61a3-dc3f-4ac1-91d9-4c73a7a9b0f9</guid>
      <link>https://share.transistor.fm/s/0bcd1711</link>
      <description>
        <![CDATA[<p>One in four people in the U.S. has been diagnosed with a gastrointestinal (GI) condition, says the co-founder and CEO of Oshi Health, Sam Holliday. The patient journey to diagnosis is costly and long—often two to four years—and filled with tests, examinations and waiting rooms. Oshi Health is a startup and CVS Health Ventures partner that uses an integrated virtual care model to scale access to care and innovation for patients struggling with GI diseases such as irritable bowel syndrome, Crohn’s disease and ulcerative colitis. There’s an emerging understanding that the signaling between the gut and the brain can get dysregulated and trigger symptoms, notes Holliday. Oshi’s approach is to calm that signaling with a combination of FDA-approved digital therapeutics and a multidisciplinary care team that includes a dietician, psychologist, nurse practitioner and gastroenterologist.</p><p><strong> </strong></p><p><strong>Learn more</strong></p><p><a href="https://oshihealth.com/">Oshi Health</a> </p><p><a href="https://www.cvshealth.com/health-care-redefined/ventures.html">CVS Health Ventures</a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>One in four people in the U.S. has been diagnosed with a gastrointestinal (GI) condition, says the co-founder and CEO of Oshi Health, Sam Holliday. The patient journey to diagnosis is costly and long—often two to four years—and filled with tests, examinations and waiting rooms. Oshi Health is a startup and CVS Health Ventures partner that uses an integrated virtual care model to scale access to care and innovation for patients struggling with GI diseases such as irritable bowel syndrome, Crohn’s disease and ulcerative colitis. There’s an emerging understanding that the signaling between the gut and the brain can get dysregulated and trigger symptoms, notes Holliday. Oshi’s approach is to calm that signaling with a combination of FDA-approved digital therapeutics and a multidisciplinary care team that includes a dietician, psychologist, nurse practitioner and gastroenterologist.</p><p><strong> </strong></p><p><strong>Learn more</strong></p><p><a href="https://oshihealth.com/">Oshi Health</a> </p><p><a href="https://www.cvshealth.com/health-care-redefined/ventures.html">CVS Health Ventures</a></p>]]>
      </content:encoded>
      <pubDate>Thu, 16 Feb 2023 03:00:00 -0500</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/0bcd1711/82a7c12b.mp3" length="19645454" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1225</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>One in four people in the U.S. has been diagnosed with a gastrointestinal (GI) condition, says the co-founder and CEO of Oshi Health, Sam Holliday. The patient journey to diagnosis is costly and long—often two to four years—and filled with tests, examinations and waiting rooms. Oshi Health is a startup and CVS Health Ventures partner that uses an integrated virtual care model to scale access to care and innovation for patients struggling with GI diseases such as irritable bowel syndrome, Crohn’s disease and ulcerative colitis. There’s an emerging understanding that the signaling between the gut and the brain can get dysregulated and trigger symptoms, notes Holliday. Oshi’s approach is to calm that signaling with a combination of FDA-approved digital therapeutics and a multidisciplinary care team that includes a dietician, psychologist, nurse practitioner and gastroenterologist.</p><p><strong> </strong></p><p><strong>Learn more</strong></p><p><a href="https://oshihealth.com/">Oshi Health</a> </p><p><a href="https://www.cvshealth.com/health-care-redefined/ventures.html">CVS Health Ventures</a></p>]]>
      </itunes:summary>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/0bcd1711/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>The Many Ways VR is Getting Real - er</title>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:title>The Many Ways VR is Getting Real - er</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">8e135cc2-8a7c-4287-a562-a4feef76e9ad</guid>
      <link>https://share.transistor.fm/s/dc745417</link>
      <description>
        <![CDATA[<p>In Part 2 of the Healthy Conversations discussion with Dr. Brennan Spiegel, professor of medicine and public health at Cedar Sinai Health System, gastroenterologist, and VR pioneer, lets us peak into the future, and see some of the many ways VR is getting “real-er” – as he puts it: “You can experience life as someone with a disability, or as a different race, or with certain physical or visual handicaps. And that can give clinicians a bit of insight to what their patients are experiencing continuously.”</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In Part 2 of the Healthy Conversations discussion with Dr. Brennan Spiegel, professor of medicine and public health at Cedar Sinai Health System, gastroenterologist, and VR pioneer, lets us peak into the future, and see some of the many ways VR is getting “real-er” – as he puts it: “You can experience life as someone with a disability, or as a different race, or with certain physical or visual handicaps. And that can give clinicians a bit of insight to what their patients are experiencing continuously.”</p>]]>
      </content:encoded>
      <pubDate>Wed, 25 Jan 2023 03:01:00 -0500</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/dc745417/ebc5f683.mp3" length="17953523" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1120</itunes:duration>
      <itunes:summary>In Part 2 of the Healthy Conversations discussion with Dr. Brennan Spiegel, professor of medicine and public health at Cedar Sinai Health System, gastroenterologist, and VR pioneer, lets us peak into the future, and see some of the many ways VR is getting “real-er” – as he puts it: “You can experience life as someone with a disability, or as a different race, or with certain physical or visual handicaps. And that can give clinicians a bit of insight to what their patients are experiencing continuously.”</itunes:summary>
      <itunes:subtitle>In Part 2 of the Healthy Conversations discussion with Dr. Brennan Spiegel, professor of medicine and public health at Cedar Sinai Health System, gastroenterologist, and VR pioneer, lets us peak into the future, and see some of the many ways VR is getting</itunes:subtitle>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/dc745417/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>A Clinic in a Headset? The Exciting New World of VR</title>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:title>A Clinic in a Headset? The Exciting New World of VR</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">003fe864-7a78-406e-91aa-5cebd88a8300</guid>
      <link>https://share.transistor.fm/s/3e1e8566</link>
      <description>
        <![CDATA[<p>In the first of a 2-part episode on Healthy Conversations, Dr. Brennan Spiegel, a professor of medicine and public health at Cedars-Sinai Health System, gastroenterologist, and VR pioneer, discusses the exciting possibilities of virtual reality in terms of its affecting the human mind, as well as chronic diseases. As he puts it, "Rather than always bringing patients to the clinic, what if we can bring the clinic to the patient?"</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In the first of a 2-part episode on Healthy Conversations, Dr. Brennan Spiegel, a professor of medicine and public health at Cedars-Sinai Health System, gastroenterologist, and VR pioneer, discusses the exciting possibilities of virtual reality in terms of its affecting the human mind, as well as chronic diseases. As he puts it, "Rather than always bringing patients to the clinic, what if we can bring the clinic to the patient?"</p>]]>
      </content:encoded>
      <pubDate>Fri, 06 Jan 2023 13:25:18 -0500</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/3e1e8566/9dec8173.mp3" length="13353758" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>832</itunes:duration>
      <itunes:summary>In the first of a 2-part episode on Healthy Conversations, Dr. Brennan Spiegel, a professor of medicine and public health at Cedars-Sinai Health System, gastroenterologist, and VR pioneer, discusses the exciting possibilities of virtual reality in terms of its affecting the human mind, as well as chronic diseases. As he puts it, "Rather than always bringing patients to the clinic, what if we can bring the clinic to the patient?"</itunes:summary>
      <itunes:subtitle>In the first of a 2-part episode on Healthy Conversations, Dr. Brennan Spiegel, a professor of medicine and public health at Cedars-Sinai Health System, gastroenterologist, and VR pioneer, discusses the exciting possibilities of virtual reality in terms o</itunes:subtitle>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/3e1e8566/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Going Digital in Suicide Prevention</title>
      <itunes:season>2</itunes:season>
      <podcast:season>2</podcast:season>
      <itunes:title>Going Digital in Suicide Prevention</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">39f9d68f-973b-4062-b34e-2faa8888e11e</guid>
      <link>https://share.transistor.fm/s/ffbb1de2</link>
      <description>
        <![CDATA[<p>In the second of a two-part episode about suicide, Dr. Seth Feuerstein, the CEO of Oui Therapeutics, discusses the exciting potential of digital therapeutics in preventing suicide.  As he says, “So we can use software to tackle problems where we already have lots of prescription options, but -- the thing that really excites me is where can we use software to solve problems that were not previously solvable.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In the second of a two-part episode about suicide, Dr. Seth Feuerstein, the CEO of Oui Therapeutics, discusses the exciting potential of digital therapeutics in preventing suicide.  As he says, “So we can use software to tackle problems where we already have lots of prescription options, but -- the thing that really excites me is where can we use software to solve problems that were not previously solvable.</p>]]>
      </content:encoded>
      <pubDate>Wed, 14 Dec 2022 08:00:00 -0500</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/ffbb1de2/b1f0d11b.mp3" length="17606899" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1098</itunes:duration>
      <itunes:summary>In the second of a two-part episode about suicide, Dr. Seth Feuerstein, the CEO of Oui Therapeutics, discusses the exciting potential of digital therapeutics in preventing suicide.  As he says, “So we can use software to tackle problems where we already have lots of prescription options, but -- the thing that really excites me is where can we use software to solve problems that were not previously solvable.</itunes:summary>
      <itunes:subtitle>In the second of a two-part episode about suicide, Dr. Seth Feuerstein, the CEO of Oui Therapeutics, discusses the exciting potential of digital therapeutics in preventing suicide.  As he says, “So we can use software to tackle problems where we already h</itunes:subtitle>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/ffbb1de2/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Dispelling Misconceptions About Suicide</title>
      <itunes:season>2</itunes:season>
      <podcast:season>2</podcast:season>
      <itunes:title>Dispelling Misconceptions About Suicide</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">93c84076-5862-4406-9bbb-e6cb2bee662f</guid>
      <link>https://share.transistor.fm/s/f931dc1b</link>
      <description>
        <![CDATA[<p>Dr. Seth Feuerstein, the CEO of Oui Therapeutics, dispels misconceptions about suicide in the first of a 2-part episode of Healthy Conversations.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Dr. Seth Feuerstein, the CEO of Oui Therapeutics, dispels misconceptions about suicide in the first of a 2-part episode of Healthy Conversations.</p>]]>
      </content:encoded>
      <pubDate>Wed, 30 Nov 2022 08:00:00 -0500</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/f931dc1b/2555e881.mp3" length="18997701" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1185</itunes:duration>
      <itunes:summary>Dr. Seth Feuerstein, the CEO of Oui Therapeutics, dispels misconceptions about suicide in the first of a 2-part episode of Healthy Conversations.</itunes:summary>
      <itunes:subtitle>Dr. Seth Feuerstein, the CEO of Oui Therapeutics, dispels misconceptions about suicide in the first of a 2-part episode of Healthy Conversations.</itunes:subtitle>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/f931dc1b/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Insights about COVID, Long COVID &amp; More</title>
      <itunes:season>2</itunes:season>
      <podcast:season>2</podcast:season>
      <itunes:title>Insights about COVID, Long COVID &amp; More</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">4365f5ef-8fa8-429e-b17e-fc3dbed0a7ed</guid>
      <link>https://share.transistor.fm/s/1b629cb9</link>
      <description>
        <![CDATA[<p>Where do things stand now in terms of COVID, Long – and even Medium COVID?  What have we learned after the past three years, and what should we, going forward?  On the latest Healthy Conversations episode, Dr. Kirsten Anderson, senior medical director for New England for Aetna and CVS Health, shares insights with Daniel, and tells why she feels the role of public health is more important than ever before now.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Where do things stand now in terms of COVID, Long – and even Medium COVID?  What have we learned after the past three years, and what should we, going forward?  On the latest Healthy Conversations episode, Dr. Kirsten Anderson, senior medical director for New England for Aetna and CVS Health, shares insights with Daniel, and tells why she feels the role of public health is more important than ever before now.</p>]]>
      </content:encoded>
      <pubDate>Fri, 18 Nov 2022 13:18:04 -0500</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/1b629cb9/88d7cdba.mp3" length="22329369" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1393</itunes:duration>
      <itunes:summary>Where do things stand now in terms of COVID, Long – and even Medium COVID?  What have we learned after the past three years, and what should we, going forward?  On the latest Healthy Conversations episode, Dr. Kirsten Anderson, senior medical director for New England for Aetna and CVS Health, shares insights with Daniel, and tells why she feels the role of public health is more important than ever before now.</itunes:summary>
      <itunes:subtitle>Where do things stand now in terms of COVID, Long – and even Medium COVID?  What have we learned after the past three years, and what should we, going forward?  On the latest Healthy Conversations episode, Dr. Kirsten Anderson, senior medical director for</itunes:subtitle>
      <itunes:keywords>Covid, CVS, Aetna, Daniel Kraft, Kirsten Anderson</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/1b629cb9/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Making the Most of Data</title>
      <itunes:season>2</itunes:season>
      <podcast:season>2</podcast:season>
      <itunes:title>Making the Most of Data</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">db6d34f3-0c2e-4612-9f34-04b8843955be</guid>
      <link>https://share.transistor.fm/s/12a4ab5d</link>
      <description>
        <![CDATA[<p>Listening to Brad Bostic, founder, chairman, and CEO of HC1 -- and Daniel’s latest guest -- you can’t help but be excited about the future: “We've got this incredible opportunity that's once in multiple generations to advance the ball, and it's because you've got access to medical information that's digital unlike you've ever had, and you've got this access to compute, and you have a collection of really intelligent, committed people working on these different areas of innovation. You put all those things together and there could not be a better time to accelerate in healthcare.”  He explains how the use of digital twins, and being able to be predictive sooner, can help.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Listening to Brad Bostic, founder, chairman, and CEO of HC1 -- and Daniel’s latest guest -- you can’t help but be excited about the future: “We've got this incredible opportunity that's once in multiple generations to advance the ball, and it's because you've got access to medical information that's digital unlike you've ever had, and you've got this access to compute, and you have a collection of really intelligent, committed people working on these different areas of innovation. You put all those things together and there could not be a better time to accelerate in healthcare.”  He explains how the use of digital twins, and being able to be predictive sooner, can help.</p>]]>
      </content:encoded>
      <pubDate>Wed, 26 Oct 2022 08:00:00 -0400</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/12a4ab5d/32a93b0d.mp3" length="24341927" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1519</itunes:duration>
      <itunes:summary>Listening to Brad Bostic, founder, chairman, and CEO of HC1 -- and Daniel’s latest guest -- you can’t help but be excited about the future: “We've got this incredible opportunity that's once in multiple generations to advance the ball, and it's because you've got access to medical information that's digital unlike you've ever had, and you've got this access to compute, and you have a collection of really intelligent, committed people working on these different areas of innovation. You put all those things together and there could not be a better time to accelerate in healthcare.”  He explains how the use of digital twins, and being able to be predictive sooner, can help.</itunes:summary>
      <itunes:subtitle>Listening to Brad Bostic, founder, chairman, and CEO of HC1 -- and Daniel’s latest guest -- you can’t help but be excited about the future: “We've got this incredible opportunity that's once in multiple generations to advance the ball, and it's because yo</itunes:subtitle>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/12a4ab5d/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>The Power of Community Medicine</title>
      <itunes:season>2</itunes:season>
      <podcast:season>2</podcast:season>
      <itunes:title>The Power of Community Medicine</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">7a4a5553-78c9-4595-b688-f2e3fbfca16c</guid>
      <link>https://share.transistor.fm/s/3d878993</link>
      <description>
        <![CDATA[This episode features Dr. James Allen, the founder and CEO of Health Systems Thinkers. Dr. Allen went from being a small-town physician in upstate New York, to working for a company in Borneo and later Bangladesh.  In the process, he became one of the foremost authorities on community medicine. Being in a remote small town made him see the workplace as part of the community.]]>
      </description>
      <content:encoded>
        <![CDATA[This episode features Dr. James Allen, the founder and CEO of Health Systems Thinkers. Dr. Allen went from being a small-town physician in upstate New York, to working for a company in Borneo and later Bangladesh.  In the process, he became one of the foremost authorities on community medicine. Being in a remote small town made him see the workplace as part of the community.]]>
      </content:encoded>
      <pubDate>Wed, 12 Oct 2022 15:49:26 -0400</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/3d878993/305df7d9.mp3" length="38167589" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>954</itunes:duration>
      <itunes:summary>This episode features Dr. James Allen, the founder and CEO of Health Systems Thinkers. Dr. Allen went from being a small-town physician in upstate New York, to working for a company in Borneo and later Bangladesh.  In the process, he became one of the foremost authorities on community medicine. Being in a remote small town made him see the workplace as part of the community.</itunes:summary>
      <itunes:subtitle>This episode features Dr. James Allen, the founder and CEO of Health Systems Thinkers. Dr. Allen went from being a small-town physician in upstate New York, to working for a company in Borneo and later Bangladesh.  In the process, he became one of the for</itunes:subtitle>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/3d878993/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>REPRISED -- Treating SCD before it hurts</title>
      <itunes:season>2</itunes:season>
      <podcast:season>2</podcast:season>
      <itunes:title>REPRISED -- Treating SCD before it hurts</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">538acc97-d8e0-4f0d-a5e5-b8db14ee813f</guid>
      <link>https://share.transistor.fm/s/8938415a</link>
      <description>
        <![CDATA[In this episode, first released in the fall of 2021, Daniel sits down with Dr. Patrick Hines, the founder and CEO at Functional Fluidics and the leading Sickle Cell Disease (SCD) researcher at Wayne State University in Detroit, where he set up a transformational study on defining the health of red blood cells. Dr. Hines also introduces us to exciting new therapies — recently approved — and the importance of being proactive with SCD.]]>
      </description>
      <content:encoded>
        <![CDATA[In this episode, first released in the fall of 2021, Daniel sits down with Dr. Patrick Hines, the founder and CEO at Functional Fluidics and the leading Sickle Cell Disease (SCD) researcher at Wayne State University in Detroit, where he set up a transformational study on defining the health of red blood cells. Dr. Hines also introduces us to exciting new therapies — recently approved — and the importance of being proactive with SCD.]]>
      </content:encoded>
      <pubDate>Thu, 29 Sep 2022 13:43:44 -0400</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/8938415a/7f427bc8.mp3" length="49054107" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1226</itunes:duration>
      <itunes:summary>In this episode, first released in the fall of 2021, Daniel sits down with Dr. Patrick Hines, the founder and CEO at Functional Fluidics and the leading Sickle Cell Disease (SCD) researcher at Wayne State University in Detroit, where he set up a transformational study on defining the health of red blood cells. Dr. Hines also introduces us to exciting new therapies — recently approved — and the importance of being proactive with SCD.</itunes:summary>
      <itunes:subtitle>In this episode, first released in the fall of 2021, Daniel sits down with Dr. Patrick Hines, the founder and CEO at Functional Fluidics and the leading Sickle Cell Disease (SCD) researcher at Wayne State University in Detroit, where he set up a transform</itunes:subtitle>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/8938415a/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Tapping into the Potential of Digital Health</title>
      <itunes:season>2</itunes:season>
      <podcast:season>2</podcast:season>
      <itunes:title>Tapping into the Potential of Digital Health</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">b1553818-50e5-43bf-a547-c88e30555312</guid>
      <link>https://share.transistor.fm/s/b8113373</link>
      <description>
        <![CDATA[Tim Blake, the founder and managing director of Semantic Consulting, helps organizations grapple with digital change and digital disruption.  And he talks with Daniel about the challenges and potential of digital healthcare – as well as what he learned as the chief information officer of the Tasmanian Health System, such as, “Sometimes problems can be far simpler than we think they are when you ask the communities that really genuinely own those problems.” ]]>
      </description>
      <content:encoded>
        <![CDATA[Tim Blake, the founder and managing director of Semantic Consulting, helps organizations grapple with digital change and digital disruption.  And he talks with Daniel about the challenges and potential of digital healthcare – as well as what he learned as the chief information officer of the Tasmanian Health System, such as, “Sometimes problems can be far simpler than we think they are when you ask the communities that really genuinely own those problems.” ]]>
      </content:encoded>
      <pubDate>Wed, 31 Aug 2022 03:00:00 -0400</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/b8113373/2f772846.mp3" length="57208383" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1429</itunes:duration>
      <itunes:summary>Tim Blake, the founder and managing director of Semantic Consulting, helps organizations grapple with digital change and digital disruption.  And he talks with Daniel about the challenges and potential of digital healthcare – as well as what he learned as the chief information officer of the Tasmanian Health System, such as, “Sometimes problems can be far simpler than we think they are when you ask the communities that really genuinely own those problems.” </itunes:summary>
      <itunes:subtitle>Tim Blake, the founder and managing director of Semantic Consulting, helps organizations grapple with digital change and digital disruption.  And he talks with Daniel about the challenges and potential of digital healthcare – as well as what he learned as</itunes:subtitle>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/b8113373/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>When Emotional Intelligence Means Higher Performance</title>
      <itunes:season>2</itunes:season>
      <podcast:season>2</podcast:season>
      <itunes:title>When Emotional Intelligence Means Higher Performance</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">058788f3-efe4-4a9a-91aa-1419dabc5c29</guid>
      <link>https://share.transistor.fm/s/5063317a</link>
      <description>
        <![CDATA[Dr. James Stoller is the Chairman of the Education Institute at Cleveland Clinic, a pulmonary critical care physician, and author of Exception to the Rule. Daniel and James sat down to discuss deficit-based thinking, medicine being a team sport, and the simple fact that "doctors, like everyone else that join organizations, expect to grow over the course of their career." ]]>
      </description>
      <content:encoded>
        <![CDATA[Dr. James Stoller is the Chairman of the Education Institute at Cleveland Clinic, a pulmonary critical care physician, and author of Exception to the Rule. Daniel and James sat down to discuss deficit-based thinking, medicine being a team sport, and the simple fact that "doctors, like everyone else that join organizations, expect to grow over the course of their career." ]]>
      </content:encoded>
      <pubDate>Wed, 17 Aug 2022 13:19:12 -0400</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/5063317a/b59d54cd.mp3" length="43089505" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1076</itunes:duration>
      <itunes:summary>Dr. James Stoller is the Chairman of the Education Institute at Cleveland Clinic, a pulmonary critical care physician, and author of Exception to the Rule. Daniel and James sat down to discuss deficit-based thinking, medicine being a team sport, and the simple fact that "doctors, like everyone else that join organizations, expect to grow over the course of their career." </itunes:summary>
      <itunes:subtitle>Dr. James Stoller is the Chairman of the Education Institute at Cleveland Clinic, a pulmonary critical care physician, and author of Exception to the Rule. Daniel and James sat down to discuss deficit-based thinking, medicine being a team sport, and the s</itunes:subtitle>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/5063317a/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Why Our Emotions Matter</title>
      <itunes:season>2</itunes:season>
      <podcast:season>2</podcast:season>
      <itunes:title>Why Our Emotions Matter</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">0ceb256c-51ab-4151-9a4b-b15927678073</guid>
      <link>https://share.transistor.fm/s/3251fc41</link>
      <description>
        <![CDATA[In clinical settings, we often suppress our emotions, ignoring what is now considered a valuable professional dataset – yet harnessing the power of our emotional life helps improve so many aspects of our work from job satisfaction to patient outcomes. It’s only a matter of time until the industry pivots away from this seemingly learned habit. Dr. Marc Brackett, Director of the Yale Center for Emotional Intelligence and author of 'Permission to Feel,' explains how to tap into the crucial ability to use our emotions wisely.  And the very real price we pay when we don’t.]]>
      </description>
      <content:encoded>
        <![CDATA[In clinical settings, we often suppress our emotions, ignoring what is now considered a valuable professional dataset – yet harnessing the power of our emotional life helps improve so many aspects of our work from job satisfaction to patient outcomes. It’s only a matter of time until the industry pivots away from this seemingly learned habit. Dr. Marc Brackett, Director of the Yale Center for Emotional Intelligence and author of 'Permission to Feel,' explains how to tap into the crucial ability to use our emotions wisely.  And the very real price we pay when we don’t.]]>
      </content:encoded>
      <pubDate>Wed, 03 Aug 2022 10:57:31 -0400</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/3251fc41/1886c988.mp3" length="59768945" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1493</itunes:duration>
      <itunes:summary>In clinical settings, we often suppress our emotions, ignoring what is now considered a valuable professional dataset – yet harnessing the power of our emotional life helps improve so many aspects of our work from job satisfaction to patient outcomes. It’s only a matter of time until the industry pivots away from this seemingly learned habit. Dr. Marc Brackett, Director of the Yale Center for Emotional Intelligence and author of 'Permission to Feel,' explains how to tap into the crucial ability to use our emotions wisely.  And the very real price we pay when we don’t.</itunes:summary>
      <itunes:subtitle>In clinical settings, we often suppress our emotions, ignoring what is now considered a valuable professional dataset – yet harnessing the power of our emotional life helps improve so many aspects of our work from job satisfaction to patient outcomes. It’</itunes:subtitle>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/3251fc41/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>The emergent genetic future of Parkinson's</title>
      <itunes:season>2</itunes:season>
      <podcast:season>2</podcast:season>
      <itunes:title>The emergent genetic future of Parkinson's</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">8e7c95ca-7e23-4954-9f58-20aa977b4262</guid>
      <link>https://share.transistor.fm/s/392f811e</link>
      <description>
        <![CDATA[Dr. James Beck, Chief Scientific Officer at the Parkinson’s Foundation, talks with Daniel about the role genetics can play with Parkinson’s, a progressive neurologic disorder with no known cause, and which affects nearly one million people in America. ]]>
      </description>
      <content:encoded>
        <![CDATA[Dr. James Beck, Chief Scientific Officer at the Parkinson’s Foundation, talks with Daniel about the role genetics can play with Parkinson’s, a progressive neurologic disorder with no known cause, and which affects nearly one million people in America. ]]>
      </content:encoded>
      <pubDate>Wed, 27 Apr 2022 15:38:39 -0400</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/392f811e/67947187.mp3" length="63724453" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1591</itunes:duration>
      <itunes:summary>Dr. James Beck, Chief Scientific Officer at the Parkinson’s Foundation, talks with Daniel about the role genetics can play with Parkinson’s, a progressive neurologic disorder with no known cause, and which affects nearly one million people in America. </itunes:summary>
      <itunes:subtitle>Dr. James Beck, Chief Scientific Officer at the Parkinson’s Foundation, talks with Daniel about the role genetics can play with Parkinson’s, a progressive neurologic disorder with no known cause, and which affects nearly one million people in America. </itunes:subtitle>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/392f811e/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Wearables: The Empowering Uses of Data</title>
      <itunes:season>2</itunes:season>
      <podcast:season>2</podcast:season>
      <itunes:title>Wearables: The Empowering Uses of Data</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">c1a325a7-8557-40d1-a6fa-0fbf7f28831c</guid>
      <link>https://share.transistor.fm/s/4a37b5fd</link>
      <description>
        <![CDATA[As Daniel Shaw, VP, Consumer Innovation Products at CVS Health tells us, "At the end of the day it's how you use this data. How are you looking at this data? In what ways are you interpreting it? And then ultimately getting to a place where you can make actual decisions on it.”  He also explains how the voice-activated Symphony ecosystem and the Attain app can help encourage both proactive and preventative behaviors.]]>
      </description>
      <content:encoded>
        <![CDATA[As Daniel Shaw, VP, Consumer Innovation Products at CVS Health tells us, "At the end of the day it's how you use this data. How are you looking at this data? In what ways are you interpreting it? And then ultimately getting to a place where you can make actual decisions on it.”  He also explains how the voice-activated Symphony ecosystem and the Attain app can help encourage both proactive and preventative behaviors.]]>
      </content:encoded>
      <pubDate>Wed, 13 Apr 2022 03:00:00 -0400</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/4a37b5fd/e3bd39cf.mp3" length="47602555" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1188</itunes:duration>
      <itunes:summary>As Daniel Shaw, VP, Consumer Innovation Products at CVS Health tells us, "At the end of the day it's how you use this data. How are you looking at this data? In what ways are you interpreting it? And then ultimately getting to a place where you can make actual decisions on it.”  He also explains how the voice-activated Symphony ecosystem and the Attain app can help encourage both proactive and preventative behaviors.</itunes:summary>
      <itunes:subtitle>As Daniel Shaw, VP, Consumer Innovation Products at CVS Health tells us, "At the end of the day it's how you use this data. How are you looking at this data? In what ways are you interpreting it? And then ultimately getting to a place where you can make a</itunes:subtitle>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/4a37b5fd/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Kidney Care Goes Digital, More Accessible</title>
      <itunes:season>2</itunes:season>
      <podcast:season>2</podcast:season>
      <itunes:title>Kidney Care Goes Digital, More Accessible</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">769fc650-980f-4aeb-beec-85f75d7a984b</guid>
      <link>https://share.transistor.fm/s/7141499f</link>
      <description>
        <![CDATA[Yonatan Adiri is out to revolutionize kidney care – and he’s already doing it. The founder and CEO of Healthy.io explains to Daniel how he’s been able to drive 53% compliance in urine testing among those patients previously noncompliant, across age groups – “The last cohort we did in the UK was 80% of which was above the age of 50. 25% between 71 and 80 years old, where we saw 40% compliance.”  Key to his success is developing technology that’s clinical grade, affordable, and computer-vision-based.]]>
      </description>
      <content:encoded>
        <![CDATA[Yonatan Adiri is out to revolutionize kidney care – and he’s already doing it. The founder and CEO of Healthy.io explains to Daniel how he’s been able to drive 53% compliance in urine testing among those patients previously noncompliant, across age groups – “The last cohort we did in the UK was 80% of which was above the age of 50. 25% between 71 and 80 years old, where we saw 40% compliance.”  Key to his success is developing technology that’s clinical grade, affordable, and computer-vision-based.]]>
      </content:encoded>
      <pubDate>Wed, 30 Mar 2022 09:50:58 -0400</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/7141499f/907b4c9c.mp3" length="70206881" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1754</itunes:duration>
      <itunes:summary>Yonatan Adiri is out to revolutionize kidney care – and he’s already doing it. The founder and CEO of Healthy.io explains to Daniel how he’s been able to drive 53% compliance in urine testing among those patients previously noncompliant, across age groups – “The last cohort we did in the UK was 80% of which was above the age of 50. 25% between 71 and 80 years old, where we saw 40% compliance.”  Key to his success is developing technology that’s clinical grade, affordable, and computer-vision-based.</itunes:summary>
      <itunes:subtitle>Yonatan Adiri is out to revolutionize kidney care – and he’s already doing it. The founder and CEO of Healthy.io explains to Daniel how he’s been able to drive 53% compliance in urine testing among those patients previously noncompliant, across age groups</itunes:subtitle>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/7141499f/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Kidney care is changing, disparities persist</title>
      <itunes:season>2</itunes:season>
      <podcast:season>2</podcast:season>
      <itunes:title>Kidney care is changing, disparities persist</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">720aced8-4efd-4c91-9fa3-cfd343292e3a</guid>
      <link>https://share.transistor.fm/s/55834fec</link>
      <description>
        <![CDATA[According to Dr. Bruce Culleton, Vice President and Chief Medical Officer, Kidney Care at CVS Health, 93% of Americans who have kidney disease don't know they have it. And he tells Daniel some of the ways physicians and nurses can address this health literacy issue. Dr. Culleton also explains some of the health equity and disparity challenges that exist in this space. For instance, African Americans are three-to-four times more likely to develop kidney failure than white Americans.]]>
      </description>
      <content:encoded>
        <![CDATA[According to Dr. Bruce Culleton, Vice President and Chief Medical Officer, Kidney Care at CVS Health, 93% of Americans who have kidney disease don't know they have it. And he tells Daniel some of the ways physicians and nurses can address this health literacy issue. Dr. Culleton also explains some of the health equity and disparity challenges that exist in this space. For instance, African Americans are three-to-four times more likely to develop kidney failure than white Americans.]]>
      </content:encoded>
      <pubDate>Wed, 23 Mar 2022 03:00:00 -0400</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/55834fec/a176bb4c.mp3" length="52726209" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1317</itunes:duration>
      <itunes:summary>According to Dr. Bruce Culleton, Vice President and Chief Medical Officer, Kidney Care at CVS Health, 93% of Americans who have kidney disease don't know they have it. And he tells Daniel some of the ways physicians and nurses can address this health literacy issue. Dr. Culleton also explains some of the health equity and disparity challenges that exist in this space. For instance, African Americans are three-to-four times more likely to develop kidney failure than white Americans.</itunes:summary>
      <itunes:subtitle>According to Dr. Bruce Culleton, Vice President and Chief Medical Officer, Kidney Care at CVS Health, 93% of Americans who have kidney disease don't know they have it. And he tells Daniel some of the ways physicians and nurses can address this health lite</itunes:subtitle>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/55834fec/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>The incomparable Bob Wachter</title>
      <itunes:season>2</itunes:season>
      <podcast:season>2</podcast:season>
      <itunes:title>The incomparable Bob Wachter</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">0516b588-7860-47a5-a664-f9a53a584dc2</guid>
      <link>https://share.transistor.fm/s/be772416</link>
      <description>
        <![CDATA[Daniel sat down with Bob Wachter to talk about the power of Twitter in public health, the continued evolution of patient-centered digital transformation, the very necessary adjustments to clinical education, his personal history as the founder of the hospitalist movement, and which technologies continue to lag in our industry.]]>
      </description>
      <content:encoded>
        <![CDATA[Daniel sat down with Bob Wachter to talk about the power of Twitter in public health, the continued evolution of patient-centered digital transformation, the very necessary adjustments to clinical education, his personal history as the founder of the hospitalist movement, and which technologies continue to lag in our industry.]]>
      </content:encoded>
      <pubDate>Wed, 09 Mar 2022 03:00:00 -0500</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/be772416/0d978aeb.mp3" length="39134949" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1628</itunes:duration>
      <itunes:summary>Daniel sat down with Bob Wachter to talk about the power of Twitter in public health, the continued evolution of patient-centered digital transformation, the very necessary adjustments to clinical education, his personal history as the founder of the hospitalist movement, and which technologies continue to lag in our industry.</itunes:summary>
      <itunes:subtitle>Daniel sat down with Bob Wachter to talk about the power of Twitter in public health, the continued evolution of patient-centered digital transformation, the very necessary adjustments to clinical education, his personal history as the founder of the hosp</itunes:subtitle>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/be772416/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Women &amp; our new genomics age</title>
      <itunes:season>2</itunes:season>
      <podcast:season>2</podcast:season>
      <itunes:title>Women &amp; our new genomics age</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">333590cc-a8f8-4f7c-a3b3-12e60f1aae5a</guid>
      <link>https://share.transistor.fm/s/dfc42b5b</link>
      <description>
        <![CDATA[Dr. Joanne Armstrong, Vice President and Chief Medical Officer for women's health and genomics at CVS Health, talks with Daniel about the incredible impact genes can play in women’s lives, helping to shape prognosis and clinical decisions, in addition to improvements in prenatal screening. Dr. Armstrong also gives us a preview of Aetna’s new guided genetic health services — now expanding into enhanced maternity and transform oncology programs.]]>
      </description>
      <content:encoded>
        <![CDATA[Dr. Joanne Armstrong, Vice President and Chief Medical Officer for women's health and genomics at CVS Health, talks with Daniel about the incredible impact genes can play in women’s lives, helping to shape prognosis and clinical decisions, in addition to improvements in prenatal screening. Dr. Armstrong also gives us a preview of Aetna’s new guided genetic health services — now expanding into enhanced maternity and transform oncology programs.]]>
      </content:encoded>
      <pubDate>Wed, 09 Feb 2022 06:54:27 -0500</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/dfc42b5b/6b6b2e88.mp3" length="48183411" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1203</itunes:duration>
      <itunes:summary>Dr. Joanne Armstrong, Vice President and Chief Medical Officer for women's health and genomics at CVS Health, talks with Daniel about the incredible impact genes can play in women’s lives, helping to shape prognosis and clinical decisions, in addition to improvements in prenatal screening. Dr. Armstrong also gives us a preview of Aetna’s new guided genetic health services — now expanding into enhanced maternity and transform oncology programs.</itunes:summary>
      <itunes:subtitle>Dr. Joanne Armstrong, Vice President and Chief Medical Officer for women's health and genomics at CVS Health, talks with Daniel about the incredible impact genes can play in women’s lives, helping to shape prognosis and clinical decisions, in addition to </itunes:subtitle>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/dfc42b5b/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Clinical genetic testing: State law, cost, and myth-based biology</title>
      <itunes:season>2</itunes:season>
      <podcast:season>2</podcast:season>
      <itunes:title>Clinical genetic testing: State law, cost, and myth-based biology</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">792adf37-6038-43c9-9b79-375cfcf3745d</guid>
      <link>https://share.transistor.fm/s/ea62d820</link>
      <description>
        <![CDATA[Daniel explores the exciting world of genetic health with Dr. Robert Nussbaum, Chief Medical Officer at Invitae. Dr. Nussbaum dispels myths about interpreting genetic data, draws important distinctions around clinical-grade testing, and describes the many important ways genetic information can be used for reproductive planning, screening, and managing disorders.]]>
      </description>
      <content:encoded>
        <![CDATA[Daniel explores the exciting world of genetic health with Dr. Robert Nussbaum, Chief Medical Officer at Invitae. Dr. Nussbaum dispels myths about interpreting genetic data, draws important distinctions around clinical-grade testing, and describes the many important ways genetic information can be used for reproductive planning, screening, and managing disorders.]]>
      </content:encoded>
      <pubDate>Wed, 26 Jan 2022 03:00:00 -0500</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/ea62d820/74d207c0.mp3" length="39022807" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1624</itunes:duration>
      <itunes:summary>Daniel explores the exciting world of genetic health with Dr. Robert Nussbaum, Chief Medical Officer at Invitae. Dr. Nussbaum dispels myths about interpreting genetic data, draws important distinctions around clinical-grade testing, and describes the many important ways genetic information can be used for reproductive planning, screening, and managing disorders.</itunes:summary>
      <itunes:subtitle>Daniel explores the exciting world of genetic health with Dr. Robert Nussbaum, Chief Medical Officer at Invitae. Dr. Nussbaum dispels myths about interpreting genetic data, draws important distinctions around clinical-grade testing, and describes the many</itunes:subtitle>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/ea62d820/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>A New age of pharmacists</title>
      <itunes:season>2</itunes:season>
      <podcast:season>2</podcast:season>
      <itunes:title>A New age of pharmacists</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">6662a09b-7794-4d4d-ab49-beedb85390bf</guid>
      <link>https://share.transistor.fm/s/c19a1df1</link>
      <description>
        <![CDATA[The past few years may have been challenging but they’ve also brought about transformation in the pharmacy setting. Daniel speaks with Dr. Dan Knecht, the chief clinical innovation officer at CVS Caremark, about ways he’s working to provide more integrative, individualized care for patients with conditions like diabetes, heart disease, and hypertension — as well as behavioral health.]]>
      </description>
      <content:encoded>
        <![CDATA[The past few years may have been challenging but they’ve also brought about transformation in the pharmacy setting. Daniel speaks with Dr. Dan Knecht, the chief clinical innovation officer at CVS Caremark, about ways he’s working to provide more integrative, individualized care for patients with conditions like diabetes, heart disease, and hypertension — as well as behavioral health.]]>
      </content:encoded>
      <pubDate>Wed, 12 Jan 2022 03:00:00 -0500</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/c19a1df1/0b7a275d.mp3" length="30486461" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1268</itunes:duration>
      <itunes:summary>The past few years may have been challenging but they’ve also brought about transformation in the pharmacy setting. Daniel speaks with Dr. Dan Knecht, the chief clinical innovation officer at CVS Caremark, about ways he’s working to provide more integrative, individualized care for patients with conditions like diabetes, heart disease, and hypertension — as well as behavioral health.</itunes:summary>
      <itunes:subtitle>The past few years may have been challenging but they’ve also brought about transformation in the pharmacy setting. Daniel speaks with Dr. Dan Knecht, the chief clinical innovation officer at CVS Caremark, about ways he’s working to provide more integrati</itunes:subtitle>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/c19a1df1/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>2021: A year of transformation</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:title>2021: A year of transformation</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">bd7ea9c5-9141-4bbf-852b-3d9e29d14685</guid>
      <link>https://share.transistor.fm/s/9f6f9917</link>
      <description>
        <![CDATA[<p>While 2021 has been a rollercoaster year, Daniel was able to cover plenty of exciting and innovative topics. He sat down with experts in public health data (discovering the data supply chain), precision oncology care, functional medicine, cutting edge red blood cell research, a venture capitalist, a former CEO and more. Health care and health care innovation is going to continue to accelerate in 2022 as the industry evolves from “intermittent, reactive sick care to a future that's continuous, proactive, anytime, anywhere, bringing us better outcomes at lower costs and bringing better health equity all around the planet.”</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>While 2021 has been a rollercoaster year, Daniel was able to cover plenty of exciting and innovative topics. He sat down with experts in public health data (discovering the data supply chain), precision oncology care, functional medicine, cutting edge red blood cell research, a venture capitalist, a former CEO and more. Health care and health care innovation is going to continue to accelerate in 2022 as the industry evolves from “intermittent, reactive sick care to a future that's continuous, proactive, anytime, anywhere, bringing us better outcomes at lower costs and bringing better health equity all around the planet.”</p>]]>
      </content:encoded>
      <pubDate>Wed, 22 Dec 2021 03:00:00 -0500</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/9f6f9917/dba92a25.mp3" length="34794651" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>868</itunes:duration>
      <itunes:summary>While 2021 has been a rollercoaster year, Daniel was able to cover plenty of exciting and innovative topics. He sat down with experts in public health data (discovering the data supply chain), precision oncology care, functional medicine, cutting edge red blood cell research, a venture capitalist, a former CEO and more. Health care and health care innovation is going to continue to accelerate in 2022 as the industry evolves from “intermittent, reactive sick care to a future that's continuous, proactive, anytime, anywhere, bringing us better outcomes at lower costs and bringing better health equity all around the planet.”</itunes:summary>
      <itunes:subtitle>While 2021 has been a rollercoaster year, Daniel was able to cover plenty of exciting and innovative topics. He sat down with experts in public health data (discovering the data supply chain), precision oncology care, functional medicine, cutting edge red</itunes:subtitle>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/9f6f9917/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>The First Wave</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:title>The First Wave</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">faab849b-5283-4afa-8431-f79cddb02c2c</guid>
      <link>https://share.transistor.fm/s/95b47806</link>
      <description>
        <![CDATA[Daniel speaks with award-winning filmmaker Matthew Heineman, who had exclusive access in March 2020 to one of New York’s largest and hardest-hit medical centers for his powerful documentary, The First Wave — as well as Dr. Nathalie Dougé, internist &amp; hospitalist — about the toll COVID has taken on health care workers. The film is in theaters now and available on Hulu.]]>
      </description>
      <content:encoded>
        <![CDATA[Daniel speaks with award-winning filmmaker Matthew Heineman, who had exclusive access in March 2020 to one of New York’s largest and hardest-hit medical centers for his powerful documentary, The First Wave — as well as Dr. Nathalie Dougé, internist &amp; hospitalist — about the toll COVID has taken on health care workers. The film is in theaters now and available on Hulu.]]>
      </content:encoded>
      <pubDate>Wed, 15 Dec 2021 03:00:00 -0500</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/95b47806/cde53e26.mp3" length="36766937" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>918</itunes:duration>
      <itunes:summary>Daniel speaks with award-winning filmmaker Matthew Heineman, who had exclusive access in March 2020 to one of New York’s largest and hardest-hit medical centers for his powerful documentary, The First Wave — as well as Dr. Nathalie Dougé, internist &amp;amp; hospitalist — about the toll COVID has taken on health care workers. The film is in theaters now and available on Hulu.</itunes:summary>
      <itunes:subtitle>Daniel speaks with award-winning filmmaker Matthew Heineman, who had exclusive access in March 2020 to one of New York’s largest and hardest-hit medical centers for his powerful documentary, The First Wave — as well as Dr. Nathalie Dougé, internist &amp;amp; </itunes:subtitle>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/95b47806/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Treating SCD before it hurts</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:title>Treating SCD before it hurts</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">725e1f7c-668b-4391-8732-d2ff7e01b406</guid>
      <link>https://share.transistor.fm/s/a80be99c</link>
      <description>
        <![CDATA[Daniel sits down with Dr. Patrick Hines, the founder and CEO at Functional Fluidics and the leading Sickle Cell Disease (SCD) researcher at Wayne State University in Detroit, where he set up a transformational study on defining the health of red blood cells — membrane stability, abnormalities, stickiness, and more. Dr. Hines also introduces us to exciting new therapies — recently approved — and the importance of being proactive with SCD.]]>
      </description>
      <content:encoded>
        <![CDATA[Daniel sits down with Dr. Patrick Hines, the founder and CEO at Functional Fluidics and the leading Sickle Cell Disease (SCD) researcher at Wayne State University in Detroit, where he set up a transformational study on defining the health of red blood cells — membrane stability, abnormalities, stickiness, and more. Dr. Hines also introduces us to exciting new therapies — recently approved — and the importance of being proactive with SCD.]]>
      </content:encoded>
      <pubDate>Wed, 20 Oct 2021 03:00:00 -0400</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/a80be99c/0990f44d.mp3" length="47880037" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1195</itunes:duration>
      <itunes:summary>Daniel sits down with Dr. Patrick Hines, the founder and CEO at Functional Fluidics and the leading Sickle Cell Disease (SCD) researcher at Wayne State University in Detroit, where he set up a transformational study on defining the health of red blood cells — membrane stability, abnormalities, stickiness, and more. Dr. Hines also introduces us to exciting new therapies — recently approved — and the importance of being proactive with SCD.</itunes:summary>
      <itunes:subtitle>Daniel sits down with Dr. Patrick Hines, the founder and CEO at Functional Fluidics and the leading Sickle Cell Disease (SCD) researcher at Wayne State University in Detroit, where he set up a transformational study on defining the health of red blood cel</itunes:subtitle>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/a80be99c/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>The institutional challenges of sickle cell</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:title>The institutional challenges of sickle cell</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">881c515e-8c07-4a75-8ecc-724d1542db97</guid>
      <link>https://share.transistor.fm/s/f79bff82</link>
      <description>
        <![CDATA[<p>Some 100,000 individuals in America alone are dealing with sickle cell. Daniel speaks with Joel Helle, Vice President of Physician Services for CVS Health, about how to change the often one-size-fits-all approach to this painful disease — to care that is not only more continuous, but personalized, and proactive.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Some 100,000 individuals in America alone are dealing with sickle cell. Daniel speaks with Joel Helle, Vice President of Physician Services for CVS Health, about how to change the often one-size-fits-all approach to this painful disease — to care that is not only more continuous, but personalized, and proactive.</p>]]>
      </content:encoded>
      <pubDate>Wed, 06 Oct 2021 09:30:50 -0400</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/f79bff82/2723db7d.mp3" length="44178023" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1103</itunes:duration>
      <itunes:summary>Some 100,000 individuals in America alone are dealing with sickle cell. Daniel speaks with Joel Helle, Vice President of Physician Services for CVS Health, about how to change the often one-size-fits-all approach to this painful disease — to care that is not only more continuous, but personalized, and proactive.</itunes:summary>
      <itunes:subtitle>Some 100,000 individuals in America alone are dealing with sickle cell. Daniel speaks with Joel Helle, Vice President of Physician Services for CVS Health, about how to change the often one-size-fits-all approach to this painful disease — to care that is </itunes:subtitle>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/f79bff82/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Reimagining private practice</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:title>Reimagining private practice</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">8c633186-0842-4076-a241-62516009acd9</guid>
      <link>https://share.transistor.fm/s/5eb3173e</link>
      <description>
        <![CDATA[<p>Dr. Nitin Gupta is the founder of Rivertowns Pediatrics, a very different type of private practice. Having practiced from Newark, NJ to Caribou, ME, he’s landed on a value-based, concierge model that works. Boiling things down, Dr. Gupta told Daniel, “You're spending more time on that computer than you are face to face with that patient.  This gives you the opportunity to be the doctor that you were meant to be, and so that's why I started this.”</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Dr. Nitin Gupta is the founder of Rivertowns Pediatrics, a very different type of private practice. Having practiced from Newark, NJ to Caribou, ME, he’s landed on a value-based, concierge model that works. Boiling things down, Dr. Gupta told Daniel, “You're spending more time on that computer than you are face to face with that patient.  This gives you the opportunity to be the doctor that you were meant to be, and so that's why I started this.”</p>]]>
      </content:encoded>
      <pubDate>Thu, 16 Sep 2021 03:00:00 -0400</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/5eb3173e/0c328720.mp3" length="47541177" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1187</itunes:duration>
      <itunes:summary>Dr. Nitin Gupta is the founder of Rivertowns Pediatrics, a very different type of private practice. Having practiced from Newark, NJ to Caribou, ME, he’s landed on a value-based, concierge model that works. Boiling things down, Dr. Gupta told Daniel, “You're spending more time on that computer than you are face to face with that patient.  This gives you the opportunity to be the doctor that you were meant to be, and so that's why I started this.”</itunes:summary>
      <itunes:subtitle>Dr. Nitin Gupta is the founder of Rivertowns Pediatrics, a very different type of private practice. Having practiced from Newark, NJ to Caribou, ME, he’s landed on a value-based, concierge model that works. Boiling things down, Dr. Gupta told Daniel, “You</itunes:subtitle>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/5eb3173e/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>The future of oncology</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:title>The future of oncology</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">2461aeca-1fcd-4c2e-8961-1e44707a7556</guid>
      <link>https://share.transistor.fm/s/6b1b9e96</link>
      <description>
        <![CDATA[<p>Daniel sits down with Dr. Kim Blackwell, former oncologist and Eli Lilly trialist who is now the Chief Medical Officer at Tempus, a technology company that has built the world's largest library of clinical and molecular data as well as an operating system to make that information accessible and useful for patients, physicians, and researchers. They discuss big data, genetic sequencing, and the tech that drives today’s transformative precision cancer treatments.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Daniel sits down with Dr. Kim Blackwell, former oncologist and Eli Lilly trialist who is now the Chief Medical Officer at Tempus, a technology company that has built the world's largest library of clinical and molecular data as well as an operating system to make that information accessible and useful for patients, physicians, and researchers. They discuss big data, genetic sequencing, and the tech that drives today’s transformative precision cancer treatments.</p>]]>
      </content:encoded>
      <pubDate>Wed, 25 Aug 2021 03:00:00 -0400</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/6b1b9e96/b5e401e7.mp3" length="45968725" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1148</itunes:duration>
      <itunes:summary>Daniel sits down with Dr. Kim Blackwell, former oncologist and Eli Lilly trialist who is now the Chief Medical Officer at Tempus, a technology company that has built the world's largest library of clinical and molecular data as well as an operating system to make that information accessible and useful for patients, physicians, and researchers. They discuss big data, genetic sequencing, and the tech that drives today’s transformative precision cancer treatments.</itunes:summary>
      <itunes:subtitle>Daniel sits down with Dr. Kim Blackwell, former oncologist and Eli Lilly trialist who is now the Chief Medical Officer at Tempus, a technology company that has built the world's largest library of clinical and molecular data as well as an operating system</itunes:subtitle>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/6b1b9e96/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Treating the whole patient at CTCA</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:title>Treating the whole patient at CTCA</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">064fee1c-c2e1-4ed1-9b24-9b7cf9681d75</guid>
      <link>https://share.transistor.fm/s/8c1b0f36</link>
      <description>
        <![CDATA[<p>Daniel sits down with Dr. Pat Basu, President &amp; CEO of Cancer Treatment Centers of America, to discuss his unique point of view on the evolution of oncology care, precision medicine, the changing role of MD MBAs like himself, his early telemedicine work with Doctor On Demand, as well as his time as a Fellow advising the White House.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Daniel sits down with Dr. Pat Basu, President &amp; CEO of Cancer Treatment Centers of America, to discuss his unique point of view on the evolution of oncology care, precision medicine, the changing role of MD MBAs like himself, his early telemedicine work with Doctor On Demand, as well as his time as a Fellow advising the White House.</p>]]>
      </content:encoded>
      <pubDate>Wed, 11 Aug 2021 03:00:00 -0400</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/8c1b0f36/0ae9449f.mp3" length="41076303" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1025</itunes:duration>
      <itunes:summary>Daniel sits down with Dr. Pat Basu, President &amp;amp; CEO of Cancer Treatment Centers of America, to discuss his unique point of view on the evolution of oncology care, precision medicine, the changing role of MD MBAs like himself, his early telemedicine work with Doctor On Demand, as well as his time as a Fellow advising the White House.</itunes:summary>
      <itunes:subtitle>Daniel sits down with Dr. Pat Basu, President &amp;amp; CEO of Cancer Treatment Centers of America, to discuss his unique point of view on the evolution of oncology care, precision medicine, the changing role of MD MBAs like himself, his early telemedicine wo</itunes:subtitle>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/8c1b0f36/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Defining functional medicine at the Cleveland Clinic</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:title>Defining functional medicine at the Cleveland Clinic</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">ce0dec38-59b7-4fba-823d-0eccb69c919f</guid>
      <link>https://share.transistor.fm/s/9dc5d5dc</link>
      <description>
        <![CDATA[<p>Daniel sits down with Dr. Mark Hyman, Head of Strategy &amp; Innovation at the Cleveland Clinic Center for Functional Medicine – “a paradigm shift in our thinking about disease.” Dr. Hyman says, “We've now got 155,000 diseases in our diagnostic category book, but they're really all driven by a smaller number of common root causes.”</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Daniel sits down with Dr. Mark Hyman, Head of Strategy &amp; Innovation at the Cleveland Clinic Center for Functional Medicine – “a paradigm shift in our thinking about disease.” Dr. Hyman says, “We've now got 155,000 diseases in our diagnostic category book, but they're really all driven by a smaller number of common root causes.”</p>]]>
      </content:encoded>
      <pubDate>Wed, 14 Jul 2021 03:00:00 -0400</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/9dc5d5dc/3177fd04.mp3" length="44958535" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1122</itunes:duration>
      <itunes:summary>Daniel sits down with Dr. Mark Hyman, Head of Strategy &amp;amp; Innovation at the Cleveland Clinic Center for Functional Medicine – “a paradigm shift in our thinking about disease.” Dr. Hyman says, “We've now got 155,000 diseases in our diagnostic category book, but they're really all driven by a smaller number of common root causes.”</itunes:summary>
      <itunes:subtitle>Daniel sits down with Dr. Mark Hyman, Head of Strategy &amp;amp; Innovation at the Cleveland Clinic Center for Functional Medicine – “a paradigm shift in our thinking about disease.” Dr. Hyman says, “We've now got 155,000 diseases in our diagnostic category b</itunes:subtitle>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/9dc5d5dc/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>The evolution of “physician culture”</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:title>The evolution of “physician culture”</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">c8b91bda-71b1-4b63-a939-b5300b1ce8a7</guid>
      <link>https://share.transistor.fm/s/83a600d2</link>
      <description>
        <![CDATA[<p>Daniel sits down with Dr. Robert Pearl, former surgeon and CEO at Permanente Medical Group for 18 years, about the culture of medicine and his new book <strong>Uncaring: How the Culture of Medicine Kills Doctors &amp; Patients</strong> (proceeds go to Doctors Without Borders). Dr. Pearl provides an unflinching diagnosis of “physician culture” dating back to Dr. Ignaz Semmelweis’ battered leather apron in 1844; second, he details the escalating costs of healthcare; and third, he addresses the danger of implicit bias in healthcare with some truly stunning examples that can only come through the lens a former physician turned health care executive.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Daniel sits down with Dr. Robert Pearl, former surgeon and CEO at Permanente Medical Group for 18 years, about the culture of medicine and his new book <strong>Uncaring: How the Culture of Medicine Kills Doctors &amp; Patients</strong> (proceeds go to Doctors Without Borders). Dr. Pearl provides an unflinching diagnosis of “physician culture” dating back to Dr. Ignaz Semmelweis’ battered leather apron in 1844; second, he details the escalating costs of healthcare; and third, he addresses the danger of implicit bias in healthcare with some truly stunning examples that can only come through the lens a former physician turned health care executive.</p>]]>
      </content:encoded>
      <pubDate>Wed, 30 Jun 2021 03:00:00 -0400</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/83a600d2/e09c7d4f.mp3" length="47853539" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1195</itunes:duration>
      <itunes:summary>Daniel sits down with Dr. Robert Pearl, former surgeon and CEO at Permanente Medical Group for 18 years, about the culture of medicine and his new book, “Uncaring: How the Culture of Medicine Kills Doctors &amp;amp; Patients” (proceeds go to Doctors Without Borders). Dr. Pearl provides an unflinching diagnosis of “physician culture” dating back to Dr. Ignaz Semmelweis’ battered leather apron in 1844; second, he details the escalating costs of healthcare; and third, he addresses the danger of implicit bias in healthcare with some truly stunning examples that can only come through the lens a former physician turned health care executive.</itunes:summary>
      <itunes:subtitle>Daniel sits down with Dr. Robert Pearl, former surgeon and CEO at Permanente Medical Group for 18 years, about the culture of medicine and his new book, “Uncaring: How the Culture of Medicine Kills Doctors &amp;amp; Patients” (proceeds go to Doctors Without B</itunes:subtitle>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/83a600d2/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Venture capital meets primary care (or PC2VC)</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:title>Venture capital meets primary care (or PC2VC)</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">bca5544b-c947-4738-bea3-c14dca813116</guid>
      <link>https://share.transistor.fm/s/6ae26dd9</link>
      <description>
        <![CDATA[<p>Daniel is a physician who wears many hats: inventor, founder, investor, and startup advisor. This week he sat down with another physician, Dr. Vineeta Agarwala, who has taken her clinical expertise to a whole other industry. Vineeta is a General Partner at Andreessen Horowitz, where she leads investments for the storied firm’s bio fund (overseeing therapeutics, diagnostics, and digital health).</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Daniel is a physician who wears many hats: inventor, founder, investor, and startup advisor. This week he sat down with another physician, Dr. Vineeta Agarwala, who has taken her clinical expertise to a whole other industry. Vineeta is a General Partner at Andreessen Horowitz, where she leads investments for the storied firm’s bio fund (overseeing therapeutics, diagnostics, and digital health).</p>]]>
      </content:encoded>
      <pubDate>Fri, 11 Jun 2021 03:00:00 -0400</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/6ae26dd9/84e526a3.mp3" length="46946829" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1172</itunes:duration>
      <itunes:summary>Daniel is a physician who wears many hats: inventor, founder, investor, and startup advisor. This week he sat down with another physician, Dr. Vineeta Agarwala, who has taken her clinical expertise to a whole other industry. Vineeta is a General Partner at Andreessen Horowitz, where she leads investments for the storied firm’s bio fund (overseeing therapeutics, diagnostics, and digital health).</itunes:summary>
      <itunes:subtitle>Daniel is a physician who wears many hats: inventor, founder, investor, and startup advisor. This week he sat down with another physician, Dr. Vineeta Agarwala, who has taken her clinical expertise to a whole other industry. Vineeta is a General Partner a</itunes:subtitle>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/6ae26dd9/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Vaccination Insights: Part II</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:title>Vaccination Insights: Part II</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">9b5a6f7f-1729-480a-85b5-9c5a17d6225b</guid>
      <link>https://share.transistor.fm/s/e172d03b</link>
      <description>
        <![CDATA[<p>Daniel sat down with Dr. Dylan George, a biosecurity and data expert from Gingko Bioworks. Dylan’s career spans academia and a number of roles in the federal government — advising the Obama administration on Ebola and, more recently, advising the Biden-Harris transition team on COVID-19. If data is the new oil, it's also the new way of protecting our kids, our families, and our communities.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Daniel sat down with Dr. Dylan George, a biosecurity and data expert from Gingko Bioworks. Dylan’s career spans academia and a number of roles in the federal government — advising the Obama administration on Ebola and, more recently, advising the Biden-Harris transition team on COVID-19. If data is the new oil, it's also the new way of protecting our kids, our families, and our communities.</p>]]>
      </content:encoded>
      <pubDate>Wed, 19 May 2021 03:00:00 -0400</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/e172d03b/de6c5aeb.mp3" length="52405353" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1308</itunes:duration>
      <itunes:summary>Daniel sat down with Dr. Dylan George, a biosecurity and data expert from Gingko Bioworks. Dylan’s career spans academia and a number of roles in the federal government — advising the Obama administration on Ebola and, more recently, advising the Biden-Harris transition team on COVID-19. If data is the new oil, it's also the new way of protecting our kids, our families, and our communities.</itunes:summary>
      <itunes:subtitle>Daniel sat down with Dr. Dylan George, a biosecurity and data expert from Gingko Bioworks. Dylan’s career spans academia and a number of roles in the federal government — advising the Obama administration on Ebola and, more recently, advising the Biden-Ha</itunes:subtitle>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/e172d03b/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Women’s Health: Part II</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:title>Women’s Health: Part II</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">78e83cb1-0020-4c64-80ab-08b894e6fcdb</guid>
      <link>https://share.transistor.fm/s/5b5b1201</link>
      <description>
        <![CDATA[<p>May is Women’s Health month, and Daniel sat down with Dr. Joanne Armstrong, Chief Medical Officer for Women's Health &amp; Genomics at CVS Health, for both a tactical and macro-level look at how we all measure up to the rest of the world in this area — including prenatal, maternal, and postpartum care, as well as breast cancer and the latest studies on unconscious bias.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>May is Women’s Health month, and Daniel sat down with Dr. Joanne Armstrong, Chief Medical Officer for Women's Health &amp; Genomics at CVS Health, for both a tactical and macro-level look at how we all measure up to the rest of the world in this area — including prenatal, maternal, and postpartum care, as well as breast cancer and the latest studies on unconscious bias.</p>]]>
      </content:encoded>
      <pubDate>Thu, 06 May 2021 03:00:00 -0400</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/5b5b1201/06cc1920.mp3" length="45856213" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1145</itunes:duration>
      <itunes:summary>May is Women’s Health month, and Daniel sat down with Dr. Joanne Armstrong, Chief Medical Officer for Women's Health &amp;amp; Genomics at CVS Health, for both a tactical and macro-level look at how we all measure up to the rest of the world in this area — including prenatal, maternal, and postpartum care, as well as breast cancer and the latest studies on unconscious bias.</itunes:summary>
      <itunes:subtitle>May is Women’s Health month, and Daniel sat down with Dr. Joanne Armstrong, Chief Medical Officer for Women's Health &amp;amp; Genomics at CVS Health, for both a tactical and macro-level look at how we all measure up to the rest of the world in this area — in</itunes:subtitle>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/5b5b1201/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Women's Health: Part I</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:title>Women's Health: Part I</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">0c33b4f2-96f7-480b-afd2-bcd288094fa7</guid>
      <link>https://share.transistor.fm/s/0af47c22</link>
      <description>
        <![CDATA[<p>Daniel speaks with Dr. Laurie Zephyrin, VP of Health Systems Equity at the Commonwealth Fund. Laurie was a key player in transforming women’s health at the VA, having trained as an OB-GYN before scaling her attention to systems, structures and culture. </p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Daniel speaks with Dr. Laurie Zephyrin, VP of Health Systems Equity at the Commonwealth Fund. Laurie was a key player in transforming women’s health at the VA, having trained as an OB-GYN before scaling her attention to systems, structures and culture. </p>]]>
      </content:encoded>
      <pubDate>Wed, 21 Apr 2021 03:00:00 -0400</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/0af47c22/8fa6d298.mp3" length="43402221" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1083</itunes:duration>
      <itunes:summary>Daniel speaks with Dr. Laurie Zephyrin, VP of Health Systems Equity at the Commonwealth Fund. Laurie was a key player in transforming women’s health at the VA, having trained as an OB-GYN before scaling her attention to systems, structures and culture.</itunes:summary>
      <itunes:subtitle>Daniel speaks with Dr. Laurie Zephyrin, VP of Health Systems Equity at the Commonwealth Fund. Laurie was a key player in transforming women’s health at the VA, having trained as an OB-GYN before scaling her attention to systems, structures and culture.</itunes:subtitle>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/0af47c22/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Vaccination Insights</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:title>Vaccination Insights</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">46be8f5a-ca3b-4442-961f-98bc5f8fe22c</guid>
      <link>https://share.transistor.fm/s/710624e6</link>
      <description>
        <![CDATA[<p>Daniel speaks with Dr. Sree Chaguturu, Chief Medical Officer, CVS Caremark about vaccine hesitancy — citing original research around common objections and physician best practices — as well as current vaccination rates, variants and boosters, and what we’ve learned as an enterprise from long term care (LTC) facilities and the federal retail pharmacy program.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Daniel speaks with Dr. Sree Chaguturu, Chief Medical Officer, CVS Caremark about vaccine hesitancy — citing original research around common objections and physician best practices — as well as current vaccination rates, variants and boosters, and what we’ve learned as an enterprise from long term care (LTC) facilities and the federal retail pharmacy program.</p>]]>
      </content:encoded>
      <pubDate>Wed, 07 Apr 2021 06:50:00 -0400</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/710624e6/b698da39.mp3" length="59798424" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1493</itunes:duration>
      <itunes:summary>Daniel speaks with Dr. Sree Chaguturu, Chief Medical Officer, CVS Caremark about vaccine hesitancy — citing original research around common objections and physician best practices — as well as current vaccination rates, variants and boosters, and what we’ve learned as an enterprise from long term care (LTC) facilities and the federal retail pharmacy program.</itunes:summary>
      <itunes:subtitle>Daniel speaks with Dr. Sree Chaguturu, Chief Medical Officer, CVS Caremark about vaccine hesitancy — citing original research around common objections and physician best practices — as well as current vaccination rates, variants and boosters, and what we’</itunes:subtitle>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/710624e6/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>At-home care</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:title>At-home care</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">e44935ce-d01f-4000-a36e-272012c89265</guid>
      <link>https://share.transistor.fm/s/0d073e0e</link>
      <description>
        <![CDATA[In this episode, we explore the latest thinking and newest innovations in at-home care for seniors. Guests include AgeWave founders,Doctors Ken and Maddy Dychtwald, our own Adam Pellegrini (SVP Enterprise Virtual Care &amp; Consumer Health), and health care futurist Zayna Khayat (author of The Future of Aging).]]>
      </description>
      <content:encoded>
        <![CDATA[In this episode, we explore the latest thinking and newest innovations in at-home care for seniors. Guests include AgeWave founders,Doctors Ken and Maddy Dychtwald, our own Adam Pellegrini (SVP Enterprise Virtual Care &amp; Consumer Health), and health care futurist Zayna Khayat (author of The Future of Aging).]]>
      </content:encoded>
      <pubDate>Mon, 08 Feb 2021 09:00:00 -0500</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/0d073e0e/380f83a9.mp3" length="23865755" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1485</itunes:duration>
      <itunes:summary>In this episode, we explore the latest thinking and newest innovations in at-home care for seniors. Guests include AgeWave founders,Doctors Ken and Maddy Dychtwald, our own Adam Pellegrini (SVP Enterprise Virtual Care &amp;amp; Consumer Health), and health care futurist Zayna Khayat (author of The Future of Aging).</itunes:summary>
      <itunes:subtitle>In this episode, we explore the latest thinking and newest innovations in at-home care for seniors. Guests include AgeWave founders,Doctors Ken and Maddy Dychtwald, our own Adam Pellegrini (SVP Enterprise Virtual Care &amp;amp; Consumer Health), and health ca</itunes:subtitle>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/0d073e0e/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>Diabetes</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:title>Diabetes</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">28abe15f-7c88-4770-8ec9-94885ecc0e51</guid>
      <link>https://share.transistor.fm/s/1e30d70b</link>
      <description>
        <![CDATA[<p>We also connected with Dr. Kenneth Snow about innovative technologies like CGM (continuous glucose monitors), early detection, and the fine line between giving patients more autonomy and the risk of overwhelming them. Lastly, we’ll hear from Rebecca Rice, pharmacist and educator, about the evolving role she plays in the life of chronic care patients via the unique HealthHub model.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>We also connected with Dr. Kenneth Snow about innovative technologies like CGM (continuous glucose monitors), early detection, and the fine line between giving patients more autonomy and the risk of overwhelming them. Lastly, we’ll hear from Rebecca Rice, pharmacist and educator, about the evolving role she plays in the life of chronic care patients via the unique HealthHub model.</p>]]>
      </content:encoded>
      <pubDate>Fri, 20 Nov 2020 11:45:20 -0500</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/1e30d70b/7f6059dc.mp3" length="23582265" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1466</itunes:duration>
      <itunes:summary>In this episode, we’ll focus on one of America’s most widespread chronic diseases: diabetes. November is American Diabetes Month, and we spoke with the CEO of the American Diabetes Association, Tracey Brown, about her own experience and how her organization is working to transform diabetes care.</itunes:summary>
      <itunes:subtitle>In this episode, we’ll focus on one of America’s most widespread chronic diseases: diabetes. November is American Diabetes Month, and we spoke with the CEO of the American Diabetes Association, Tracey Brown, about her own experience and how her organizati</itunes:subtitle>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/1e30d70b/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>COVID-19 Reset</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:title>COVID-19 Reset</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">1f695ac2-8424-4674-9810-0c212f30d12a</guid>
      <link>https://share.transistor.fm/s/0bb19027</link>
      <description>
        <![CDATA[There might not be a specific moment when we can hit the reset button and start to tackle systemic healthcare challenges with a clean slate, but smaller resets are already underway. Join us as we examine what a COVID-19 Reset looks like for doctors, nurses, and other healthcare professionals.

In this episode, we spoke with Dr. Rushika Fernandopulle, founder and CEO of Iora Health, about how physicians have addressed the pandemic in their own practices and the changing perceptions around value based care. We also spoke to Dr. Dan Knecht and Angie Meoli, for insight into how CVS is changing its own systems.

One of the most eye-opening impacts of COVID-19 has been the dramatic disparities highlighted in our healthcare system. Dr. Dela Taghipour and Dr. Nadia Abuelezam will discuss how we can collectively reimagine community healthcare to address those disparities.]]>
      </description>
      <content:encoded>
        <![CDATA[There might not be a specific moment when we can hit the reset button and start to tackle systemic healthcare challenges with a clean slate, but smaller resets are already underway. Join us as we examine what a COVID-19 Reset looks like for doctors, nurses, and other healthcare professionals.

In this episode, we spoke with Dr. Rushika Fernandopulle, founder and CEO of Iora Health, about how physicians have addressed the pandemic in their own practices and the changing perceptions around value based care. We also spoke to Dr. Dan Knecht and Angie Meoli, for insight into how CVS is changing its own systems.

One of the most eye-opening impacts of COVID-19 has been the dramatic disparities highlighted in our healthcare system. Dr. Dela Taghipour and Dr. Nadia Abuelezam will discuss how we can collectively reimagine community healthcare to address those disparities.]]>
      </content:encoded>
      <pubDate>Fri, 16 Oct 2020 09:30:00 -0400</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/0bb19027/02edbccd.mp3" length="24028015" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1493</itunes:duration>
      <itunes:summary>There might not be a specific moment when we can hit the reset button and start to tackle systemic healthcare challenges with a clean slate, but smaller resets are already underway. Join us as we examine what a COVID-19 Reset looks like for doctors, nurses, and other healthcare professionals.

In this episode, we spoke with Dr. Rushika Fernandopulle, founder and CEO of Iora Health, about how physicians have addressed the pandemic in their own practices and the changing perceptions around value based care. We also spoke to Dr. Dan Knecht and Angie Meoli, for insight into how CVS is changing its own systems.

One of the most eye-opening impacts of COVID-19 has been the dramatic disparities highlighted in our healthcare system. Dr. Dela Taghipour and Dr. Nadia Abuelezam will discuss how we can collectively reimagine community healthcare to address those disparities.</itunes:summary>
      <itunes:subtitle>There might not be a specific moment when we can hit the reset button and start to tackle systemic healthcare challenges with a clean slate, but smaller resets are already underway. Join us as we examine what a COVID-19 Reset looks like for doctors, nurse</itunes:subtitle>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/0bb19027/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>COVID-19 Recovery</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:title>COVID-19 Recovery</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">69589554-a3ee-4e3b-bff5-1534654f6b9b</guid>
      <link>https://share.transistor.fm/s/7b5cf573</link>
      <description>
        <![CDATA[<p>In the second episode of Healthy Conversations — an open discussion among healthcare professionals about innovation, what we're learning on the front lines of this pandemic, and how our industry is changing in real time — we turn our attention to Recovery. Data is critical in addressing the challenges of COVID-19 and influences so many of our daily, clinical decisions. How will big data, more specifically “distilling multiple biometric data streams,” transform medicine moving forward? </p><p><br></p><p>Join our hosts, Doctors Dela Taghipour and Daniel Kraft, in conversation with Dr. Eric Topol (Scripps Research Translational Institute), Dr. Caroline Buckee (Harvard T.H. Chan School of Public Health), Adam Pellegrini, and Firdaus Bhathena (CVS Health).</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In the second episode of Healthy Conversations — an open discussion among healthcare professionals about innovation, what we're learning on the front lines of this pandemic, and how our industry is changing in real time — we turn our attention to Recovery. Data is critical in addressing the challenges of COVID-19 and influences so many of our daily, clinical decisions. How will big data, more specifically “distilling multiple biometric data streams,” transform medicine moving forward? </p><p><br></p><p>Join our hosts, Doctors Dela Taghipour and Daniel Kraft, in conversation with Dr. Eric Topol (Scripps Research Translational Institute), Dr. Caroline Buckee (Harvard T.H. Chan School of Public Health), Adam Pellegrini, and Firdaus Bhathena (CVS Health).</p>]]>
      </content:encoded>
      <pubDate>Thu, 10 Sep 2020 09:00:00 -0400</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/7b5cf573/c05fb9b2.mp3" length="23153159" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1434</itunes:duration>
      <itunes:summary>In the second episode, we turn our attention to recovery. Data is critical in addressing the challenges of COVID-19 and influences so many of our daily, clinical decisions. How will big data, more specifically “distilling multiple biometric data streams,” transform medicine moving forward?</itunes:summary>
      <itunes:subtitle>In the second episode, we turn our attention to recovery. Data is critical in addressing the challenges of COVID-19 and influences so many of our daily, clinical decisions. How will big data, more specifically “distilling multiple biometric data streams,”</itunes:subtitle>
      <itunes:keywords>403121</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/7b5cf573/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>COVID-19 Response</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:title>COVID-19 Response</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">81f64cdb-6c7f-407f-9624-e0f70918adc6</guid>
      <link>https://share.transistor.fm/s/65c19cce</link>
      <description>
        <![CDATA[In the first of three COVID-19-focused episodes, listen in on robust discussions with CVS Health leaders and Dr. Scott Gottlieb, former commissioner of the U.S. Food and Drug Administration, as they discuss the importance of testing, as well as how systemic racism is impacting the pandemic response.]]>
      </description>
      <content:encoded>
        <![CDATA[In the first of three COVID-19-focused episodes, listen in on robust discussions with CVS Health leaders and Dr. Scott Gottlieb, former commissioner of the U.S. Food and Drug Administration, as they discuss the importance of testing, as well as how systemic racism is impacting the pandemic response.]]>
      </content:encoded>
      <pubDate>Mon, 10 Aug 2020 08:00:00 -0400</pubDate>
      <author>CVS Health</author>
      <enclosure url="https://media.transistor.fm/65c19cce/d9128e68.mp3" length="31955987" type="audio/mpeg"/>
      <itunes:author>CVS Health</itunes:author>
      <itunes:duration>1994</itunes:duration>
      <itunes:summary>In the first of three COVID-19-focused episodes, listen in on robust discussions with CVS Health leaders and Dr. Scott Gottlieb, former commissioner of the U.S. Food and Drug Administration, as they discuss the importance of testing, as well as how systemic racism is impacting the pandemic response.</itunes:summary>
      <itunes:subtitle>In the first of three COVID-19-focused episodes, listen in on robust discussions with CVS Health leaders and Dr. Scott Gottlieb, former commissioner of the U.S. Food and Drug Administration, as they discuss the importance of testing, as well as how system</itunes:subtitle>
      <itunes:keywords>healthy conversations, cvs health, COVID-19, Dr. Daniel Kraft, testing, strategies, access to care</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/65c19cce/transcript.txt" type="text/plain"/>
    </item>
  </channel>
</rss>
